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Abstract
Volumetric muscle loss overwhelms skeletal muscle’s ordinarily capable regenerative machinery,
resulting in fibrosis and severe functional deficits which have defied clinical repair
strategies. My work spans the design and preclinical evaluation of implants intended to drive
the cell community of injured muscle toward a regenerative state, as well as the development
of an understanding of the molecular responses of this cell community to biomaterial interventions.
I demonstrate a new class of biomaterial by leveraging the productive capacity of
sacrificial hollow fiber membrane cell culture; I show specifically that unique threads of
whole extracellular matrix can be isolated by solvent degradation of cultured hollow fiber
systems and that this matrix exhibits composition and structure appropriate for wound healing
applications. I additionally demonstrate the application of an emerging pore characterization
technique and contribute a new open source software for evaluation of mesoporous pore
diameter distribution and surface area, key properties governing the performance of sacrificial cell
culture materials. Toward a better understanding of the biomolecular systems mediating implant
efficacy, I demonstrate the first transcriptomic investigation of a specific promising
combinatorial cell-scaffold implant in a rat model of volumetric muscle loss, showing an expedited
recovery of muscle contractile force concurrent with a coordinated upregulation of
peripheral neuroregenerative signaling. Together, these findings establish a new scalable approach
for the production of biomimetic implant materials in vitro as well as molecular targets informing
the design of promising muscle regenerative biomaterials.
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Chapter 1
Introduction
A. The Cell Community of Skeletal Muscle in Health and Injury
Skeletal muscle is a complex tissue which functions to enable locomotion through the
transmission of force about joints. It represents the most massive constituent of the human body
by mass, representing up to ~40% of adult male body mass1,2 and therefore is a major contributing
factor in resting energy expenditure3 despite exhibiting a specific metabolic rate an order of
magnitude lower than that of the major organs.4 This tissue manifests largely as bilateral pairs of
muscles comprising a specialized community of cells containing the molecular machinery which
transduces action potentials into muscle contractions, producing forces which are carried across
musculotendinous junctions to bone, enabling movement.
Much of the fundamental anatomy of skeletal muscle was explored in depth in the 19th
century, with a remarkable number of early histological studies exploring the complex anatomy
and physiology of the muscle-nerve interface across different pathologies.5 Muscle is principally
composed of cylindrical cells (myofibers) approximately 100 µm in diameter with a length of up
to several centimeters and organized into bundles (fascicles) separated into a honeycomb structure
by a distinct connective tissue (perimysium) comprising thick and thin layers composed primarily
of the fibrillar collagens I, III, and V,6 though the precise amount and composition of both the
perimysium and the finer matrix encasing individual myofibers (endomysium) can vary
considerably between muscles of different function and age.7 The perimysium further hosts nerve
fibers and arterioles branching into capillaries supplying the endomysium as well as corresponding
venules. Muscle contraction is enabled by the action of complex protein superstructures termed
myofibrils; Myofibrils are bundled in sarcomeres partitioned by z-discs, complex structures which
1

contain the largest human protein, the up-to 3000 kDa Titin, estimated to represent 8.5% of total
myofibril protein.8,9 Within each sarcomere reside “thick” and “thin” myofibril filaments
composed principally of myosin and actin, respectively; myosin filaments are anchored to the
center of the sarcomere (the “M-line”), while actin filaments are anchored to the z-discs. Muscle
contraction is produced when these actin filaments are made to overlap myosin; action potentials
stimulate myofibers to release Ca2+ from the sarcoplasmic reticulum into the sarcoplasm, where it
binds a troponin-tropomyosin complex to uncover a binding site for myosin on actin.
Conformational changes induced by binding of ATP to myosin and subsequent dissociation of P i
and ADP lead to a strong association of its actin-binding domain with actin, forming the canonical
“cross-bridge”10 which pulls actin filaments, bringing their associated z-discs closer together. An
additional ATP-myosin binding event results in dissociation of the myosin-actin cross-bridge,
concluding the cycle. While myofibers represent the critical contractile cell of muscle, skeletal
muscle is supported by a broader community of resident and injury-responsive infiltrating cells.
The innate heterogeneity of these cell populations has presented challenges in terms of the
identification of reliable molecular markers. However, improvements in methods have led to
emerging evidence and interest in the roles of these cells in normal muscle function, injury, and
regeneration.
The cells of the skeletal muscle community can be broadly divided based on their capability
for myogenic differentiation; In 1961, analysis of frog muscle electromicrographs by Alexander
Mauro11 indicated the presence of a previously unknown cell type residing between the cell
membrane (sarcolemma) of myofibers and the basal lamina of the basement membrane. These
satellite cells –so called for their adjacency to myofibers- are now known to be requisite for the
regeneration of skeletal muscle.12,13 In their quiescent state, satellite cells tend to overexpress
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PAX7, a transcription factor which in these cells has been shown to regulate the transcription of
hundreds of genes through a combination of paired domain and homeobox domain DNA binding.14
Upon mild muscle injury, these cells are “activated,” having been observed to undergo a phase of
proliferation concurrent with coexpression of PAX7, MYF5, and ultimately MYOD. MYF 5 and
MYOD appear to bind identical loci, with MYF5 promoting histone acetylation while MYOD
participates in histone acetylation and the recruitment of RNA polymerase II, initiating
transcription of the myogenic program.15

Through a variety of mechanisms, mild muscle

damage incurred by exercise or trauma facilitates the action of several signals which serve to
activate satellite cells, including HGF, MGF, and FGFs, with Wnt and Notch signaling also having
prominent roles.16 In particular, myofibers contain mechanosensitive Ca2+ import channels which
are thought to respond to stretching by importing Ca2+ into the cytoplasm of the myofiber
(sarcoplasm), where it binds calmodulin.17 Calmodulin is bound by nitric oxide synthase (NOS),
eliciting electron transfer from NADPH to an FAD domain and finally the heme prosthetic group
of NOS, after which the enzyme catalyzes the conversion of arginine to citrulline and gaseous
NO.18 NO freely diffuses across the sarcolemma into the extracellular matrix, where it may
participate in conversion of the zymogenic form of the matrix metalloproteinase (MMP) MMP-2
to its active form through a nitrosylation mechanism known to occur in MMP-9 activation.19-21
MMP-2 participates in proteolytic cleavage of ECM, liberating HGF bound to collagen and other
ECM constituents.22-25 The binding of HGF with its receptor c-Met and resulting activation of the
c-Met signaling pathway26 is a key early step in satellite cell activation, and the intramuscular
injection of exogenous HGF has been shown to activate quiescent satellite cells in vivo27, though
there also appears to be a negative feedback effect of high concentrations of HGF (>50 ng/mL) on
satellite cell proliferation in vitro mediated by an upregulation of myostatin.28 During this period
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of proliferation, Pax7+/Myf5- satellite stem cells can produce two daughter cells whose fates are
determined by their orientation relative to the myofiber and basal lamina; in this asymmetric
division the myofiber-facing daughter cell upregulates Myf5 expression and becomes committed
toward a myogenic fate (a satellite myogenic cell) while the daughter cell in contact with the basal
lamina remains Myf5-, which together with the planar symmetric division of Pax7+/Myf5- cells
serves to replenish the pool of quiescent satellite cells.29,30Pax7+/Myf5+ cells also undergo planar
division in which case both daughters are committed to myogenesis.31
Following activation, satellite cells –at this point often classified as myoblasts- exhibit a
remarkable ability to migrate to sites of injury across relatively large distances both along32 and
between myofibers, with some evidence indicating that these cells can migrate between adjacent
muscles.33,34 A precise mechanism of myoblast migration has yet to be described, but many of the
relevant molecular participants have been identified. Myoblasts express receptors for a number of
chemokines released by damaged myofibers and other cells which appear to promote myoblast
migration in a manner that is independent of their effects on leukocyte recruitment.35-37 Syndecan4, a well described transmembrane receptor for ECM components, participates in signal
transduction governing cell proliferation and motility38, and has been directly implicated in
regulating the migration of satellite cells through RhoA39, with inhibition of this signaling also
shown to impair focal adhesion formation40. The activity of matrix metalloproteinases –especially
MMP-9- is necessary for normal myoblast migration across the ECM and basal lamina41,42, and
given the promotion of MMP activity by ECM-resident growth factors such as bFGF43 and HGF44,
the liberation of additional ECM-bound factors during migration could play an important role in
the guidance of myoblasts to injuries. The physical properties and spatial constraints of the ECM
substrate also guide cell behavior in migration, with cells responding through multiple methods of
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ECM digestion and turnover, including the diffuse release, cell surface localization, or lysosomal
localization of proteases.45 Upon arriving at a site of injury, myoblasts undergo a program of
differentiation by which they can fuse with each other to form immature myocytes termed
myotubes which themselves fuse to the sealed ends of existing damaged myofibers form a nascent
regenerating myofiber.46 Myogenin is a key myogenic regulatory factor (MRF) which in 1989 was
shown to direct myoblasts toward differentiation and fusion.47
Intriguingly, while satellite cells are generally accepted as the principal contributors to
myogenesis, some nonclassical muscle interstitial cells are capable of myogenic differentiation
under certain conditions. Mitchell et al identified a subset of PW1+/Pax7- interstitial cells
(myoPICs) participating in myotube formation in vitro and in vivo that were shown to be of a
separate embryonic lineage from satellite cells (PW1+/Pax7+) by their absence of positive
recombinant β-galactosidase staining in Pax3Cre × RosalacZ mice, though they do express both
Pax3 and Pax7 upon commitment to a myogenic program. 48 PICs appear to exhibit potential for
skeletal muscle, smooth muscle, and fibro-adipogenic differentiation; further, a subset of PICs
expressing PDGFRα exhibits an adipocyte-like pattern of gene expression in vitro and may have
some relation to populations of fibro-adipogenic progenitors (FAPs) identified in skeletal
muscle.49 Recent evidence demonstrating a responsiveness of PICs to satellite cell depletion
and an increased PIC population during rescue of myofiber atrophy by pharmacological
inhibition of AcvR2B suggests physiological roles for PICs in muscle regeneration warranting
further study.50
Rouget cells, a variety of contractile cell encircling capillary endothelial cells first
described by Eberth51 and Rouget52-54 and recoined as “pericyten” (pericytes) by Zimmerman 55,
are thought to regulate blood flow in capillaries through their contractility. However, a body of
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evidence has emerged demonstrating the multipotent differentiability of these cells –as well as
their mesoangioblast counterparts in the large vessels- toward osteogenic, chondrogenic,
adipogenic, and myogenic lineages 56; in fact, Crisan et al demonstrated that pericytes express
mesenchymal stem cell (MSC) markers and display MSC-like behavior in culture regardless of
their tissue of origin, intriguingly suggesting that MSCs found in adult organs may arise from
a subset of pericytes.57 Further, they demonstrated that these cells have an independent
myogenic potential; when sorted pericytes were injected into cardiotoxin-injured skeletal
muscles of immunodeficient mice and assessed three weeks post-injection, myotubes
expressing human spectrin with central nuclei were identified, suggesting some pericytes
exhibit the ability to participate in myogenesis. Interestingly, pericytes with myogenic potential
do not appear to express the classic molecular markers of myogenesis during differentiation
(Pax7, Myf5, or MyoD) until terminal differentiation, further distinguishing them from the
canonical satellite cell population. 58 Evidence suggests that a natural contribution of skeletal
muscle pericytes to myogenesis occurs mostly in the postnatal period, with minimal
contribution toward adult myogenesis, even after acute cardiotoxin-induced injury59.
Nonetheless, satellite cells are responsive to pericyte-secreted paracrine factors promoting
quiescence (ANGPT1) and differentiation (IGF1), suggesting a potential indirect role for
pericytes in muscle regeneration 60. Myoblasts additionally exhibit pericyte-like patterns of gene
expression –aside from maintaining Myf5 expression- when exposed to Dll4 and PDGF-BB from
adjacent endothelium, suggesting some “pericytes” in skeletal muscle may derive from a satellite
cell lineage61.

Despite the apparent minimal direct contribution of pericytes to adult

myogenesis, their ability to contribute to muscle regeneration following injection,
underexplored paracrine crosstalk, and multipotency compel further characterization of this cell
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population. In particular, the lack of highly specific markers for pericytes has to-date hindered
thorough characterization and is critical for future insight into the roles of pericytes in
myogenesis.
A case of induced fibroblast-myoblast transition was highlighted in a landmark study by
Davis, Weintraub, and Lasser in which transfection of MYOD cDNA into 10T1/2 embryonic
mouse fibroblast-like cells converted them to a myoblast-like phenotype62; fibroblasts have also
been observed to undergo myotube formation when cultured in the presence of differentiating
myoblasts in vitro.63 Ito et al further implicated a number of coresident myoblast-expressed
transcription factors in a myogenic transition of mouse tail-tip fibroblasts, including Pax3, Pax7,
Mef2b, Pitx1, Mef2b, and Pitx1. These induced muscle progenitors were, however, not
successfully expanded in culture.64 While a similar approach involving adenoviral delivery of
MYOD demonstrated that transformed mouse fibroblasts can participate in myofiber formation in
both immunodeficient and immunocompetent mice65, the anti-proliferative effects of exogenous
MYOD hinders potential therapeutic applications and it is not clear that fibroblast-myoblast
transition is a naturally occurring process in vivo.
Adding to the complexity of skeletal muscle regeneration is the myriad ways in which an
arsenal of muscle ancillary cells shape the muscle microenvironment and secrete paracrine signals
influencing cells with myogenic potential. Specifically, immune cells including neutrophils,
monocytes/macrophages, dendritic cells, and CD4+/CD8+/regulatory T cells are now known to
indirectly contribute significantly to skeletal muscle regeneration; while mechanisms of immune
cell involvement in muscle regeneration are understood mostly in broad terms, they are now
intensely studied for the insight they may lend to VML pathobiology and treatment.
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Neutrophils -referred to as such due to Ehrlich’s observation that they tend to retain neutral
staining solutions66- are phagocytic cells of the innate immunity and the predominant form of
granulocytes, cells which contain membrane-bound vesicles harboring proteases and signaling
peptides which can be exocytosed for a variety of purposes.67 They are recognized as the chief
immune cell initially infiltrating skeletal muscle following muscle trauma, peaking in the
immediate hours post-injury and generally declining rapidly after one day.68 Several in vitro
studies have established that while neutrophils have roles in debris clearance following injury, they
can cause significant damage to otherwise viable myofibers through their secretion of reactive
oxygen species (ROS), though the contribution of neutrophils to host-cell damage in vivo is less
clear.69,70 Interestingly, medium conditioned by injury of myofibers promotes neutrophil
chemotaxis and ROS production in vitro71, and exercise has been shown to increase production of
the neutrophil chemoattractant IL-8 in vivo.72 However, in VML the more probable chief
contributor to neutrophil recruitment and priming following injury is injury-induced cell rupture
and the resulting exposure of damage associated molecular patterns (DAMPs) recognized by cell
surface receptors on circulating neutrophils as well as macrophages; these include the formylated
peptides produced by both bacteria and mitochondria (bacterially derived by endosymbiosis),
contributing to the apparent similarities between sterile inflammation and bacterial infection.73-76
During infections, neutrophils form structures called neutrophil extracellular traps (NETs) which
contain locally high concentrations of cytotoxic compounds. Recent evidence suggests that
exposure to host mitochondrial DAMPs (mtDAMPs) may impair the formation of NETs and ROS
production, possibly driving neutrophil behavior toward phagocytosis instead of degranulation 77.
Treatment of neutrophils with mtDAMPs was also shown to induce a tolerance whereby these cells
become less responsive to further inflammatory stimulation. Conversely, another recent study
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suggests increased NET formation and ROS production in response to endogenous mtDNA78, so
these may represent competing processes in the wound microenvironment. Regardless,
extracellular mtDNA has been shown to be a potentially useful prognostic indicator for
inflammation in trauma while data remains unclear on the predictive power of extracellular formyl
peptides.79 These aspects of neutrophil physiology do not appear to have been explored in the
context of skeletal muscle trauma, but may participate in the degree of inflammatory response
observed in the implantation of therapeutic biological materials containing residual DAMPs. As
neutrophils (as well as macrophages) are capable of myofiber lysis via ROS, enzymatic inhibition
of this process may be useful where it exacerbates muscle trauma, as in VML80.
Macrophages are another immune cell type responsive to muscle injury, developing from
circulating monocytes and undergoing extravasation into muscle in response to myofiber and
neutrophil-secreted chemokines and DAMPs. They are among the longest-lived transient residents
of injured and regenerating skeletal muscle, increasing rapidly in number roughly 2 days postinjury as neutrophils decline, and in some cases persisting for several weeks. While macrophages
are well-known for their functions in pathogen and foreign body phagocytosis, evidence has
emerged demonstrating roles in the skeletal muscle inflammatory and regenerative responses
which vary with time course and degree of injury, evident in changes to their secretomes.
Macrophages initially infiltrating muscle tend to have a pro-inflammatory effect, secreting
relatively high levels of IL-12 as well as reactive oxygen and nitrogen intermediates. In typical
mild muscle injury, a phenotypic transition toward a pro-constructive state is observed in the
macrophage population several days post-injury, coinciding with greater secretion of IL-10 and
TGF-β.81 These alternative macrophage phenotypes were originally categorized by Mills et al
based on their expression of nitric oxide and polyamines, respectively.82 The former group were
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categorized as “M1” while the latter were referred to as “M2.” Subsequent studies have focused
on the differing roles of these macrophage metabolic programs in disease, but recent evidence
suggests a spectrum of macrophages phenotypes rather than a Boolean metabolic switch. In Novak
et al’s examination of macrophage behavior following muscle laceration in mice, it is noted that
the gene expression profiles of assessed macrophages did not correspond to the classical M1/M2
paradigm observed in vitro; rather, they exhibited substantial heterogeneity.83 However, regardless
of categorization, the general inflammatory-to-constructive macrophage transition in skeletal
muscle is well attested.84 In general, interventions which promote this transition have demonstrated
improved myogenesis and reduced fibrosis.85,86 Evidence suggests that inflammatory macrophages
closely associate with proliferating satellite cells while those secreting anti-inflammatory factors
associate with differentiating (MyoG+) myogenic precursors.87 Further, depleting circulating
monocytes in mice in the preceding study completely prevented muscle regeneration, while
depletion of macrophages at later time points following injury reduce regenerating myofiber size.
Fascinatingly, Ceafalan et al recently demonstrated by electron microscopy that macrophages
establish direct cell-to-cell contacts with myogenic precursor cells from satellite cell activation
through myoblast differentiation.88 They further observed active exchange of secretory vesicles
between these cells, suggesting potential modulation of cell behavior by well-known protein
factors, but also epigenetic actors such as microRNAs, known to be shuttled through vesicular
transport.89,90
T cells represent another important -though rather unexpected- participant in skeletal
muscle regeneration; specifically, Burzyn et al showed that a population of regulatory T cells (Treg)
accumulates precisely during the inflammatory-to-constructive macrophage transition. They
profiled the transcriptome of this Treg population by microarray to show that Treg cells differentially
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express several hundred transcripts relative to their closest-expressing cousins (adipose Treg cells).
Further, depletion of Treg cells in injured mouse muscle resulted in a disorganized pattern of
myofiber regeneration as well as increased collagen deposition. While thorough descriptions of
Treg roles in injured skeletal muscle have yet to be defined, evidence indicates that their absence
results in absence of the normal M1-M2 macrophage transition, causing chronic inflammation and
fibrosis.91 Burzyn et al recently published improved methods for isolation and characterization of
Treg cells which will doubtlessly enable deeper study of their participation in the regeneration of
injured muscle.92
Perhaps the most poorly understood yet consequential cell population in skeletal muscle
are the fibroadipogenic progenitors (FAPs), a population of muscle-interstitial multipotent cells
which exhibit substantial heterogeneity. Recent research has identified that FAPs expressing
Vcam1 exhibit a pro-fibrotic gene expression profile in period following injury, and are notably
persistent in the event of macrophage depletion.93 FAPs exhibit the capability to differentiate into
fibroblasts and adipocytes and are the primary source of fibrosis and adipogenesis following
muscle injury.93 Intriguingly, despite being the chief contributors to fibrosis, preventing FAP
cells (Sca1+/CD45-/CD31-/α7-integrin-) from proliferating and differentiation through Nilotinib
treatment impairs regeneration of muscle from acute injury, possibly due to a contribution of
FAPs to satellite cell proliferation.94 Lukjanenko et al recently showed that FAP function is
dramatically impaired in senescence; transcriptome profiling revealed that the ability of FAPs to
produce WISP1 is dramatically reduced with age, and that WISP1-/- mice exhibited unusually
small myofibers following regeneration, which was further shown to be preventable through
treatment with exogenous WISP1.95 Thus, initial indications are that FAP cells, like others in the
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skeletal muscle cell community, exhibit cross-talk with myogenic progenitors requisite for
normal tissue assembly in regeneration.
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Table 1. FACS Gating Strategies for the Skeletal Muscle Cell Community
+FACS markers

-FACS markers

Refs

Dendritic cells

Highly heterogeneous - No definitive gating strategy yet developed

96

Endothelial cells

CD31+ + α7-integrin+

CD45- + F4/80-

97

FAPs

Sca1+

α7-integrin- + CD31- + CD45- + F4/80-

97

Macrophages

CD45+ + F4/80+

97

Macrophages, M1-like

CD45+ + CD11b+ + CD86+

98

Macrophages, M2-like

CD45+ + CD11b+ + CD163+

98

Pan-myeloid cells

CD45+ + CD11b

98

Pericytes

CD146+

CD34- + CD45- + CD56-

99

Satellite cells

α7-integrin+

CD45- + F4/80- + CD31-

97

Schwann cells

P75NTR+

100-102

T lymphocytes

CD3+ + CD4+ and CD3+ + CD8α+

98
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Cell type

B. Volumetric Muscle Loss
As intimated in the previous section, skeletal muscle is host to a diverse cell community
which coordinates a robust regenerative program following trauma leading to functional recovery;
however, in cases where large volumes (>20%) of muscle are lost to trauma, recovery is hindered
due to myofiber regeneration being substituted by deposition of scar tissue following a period of
prolonged inflammation. Referred to as volumetric muscle loss (VML), these injuries contribute
to significant disability. In a 2016 review of US Army service members with documented VML
injuries leading to medical retirement, condition was counterintuitively seen to deteriorate with
time; medical evaluations observed muscle-related loss of motion and pain as well as increases in
disability rating over time103. Aside from diligent wound debridement, skin graft closures,
generally ineffective physical therapy, and pain management, there exists no consensus standard
of care for VML leading to appreciable functional recovery. This is compounded by the fact that
VML injuries have a naturally heterogeneous presentation. For example, while a VML injury
resulting from typical bullet wounds might be confined to a relatively small area with substantial
healthy tissue remaining, those resulting from primary blast injuries are more likely to result in
transection of major nerves, blood vessels, and bone, as well as deep tissue infections (occurring
in 27%-77% of open fracture wounds)104-108, necessitating more aggressive treatment and
complicating development of a one-size-fits-all solution.
While the general anatomy and physiology of muscle has been explored for centuries, it
is largely in the past decade that a substantial interdisciplinary effort to address the unique
challenges of VML has coalesced, burgeoned by interest and clinical data generated by the
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ongoing Global War on Terror109,110.

Figure 1: Research Articles Related to Volumetric Muscle Loss Indexed by PubMed
Interest in volumetric muscle loss has increased substantially in recent years, as evidenced
by the past decade’s positive trend in the number of new PubMed-indexed original research articles
containing the keyword “volumetric muscle loss” over time. Beginning with a 2010 case report by
Mase et al detailing positive functional recovery in the first tissue engineering-based treatment of
a human VML injury, the body of VML-related literature now encompasses nearly 200 original
research articles and case reports (Figure 1).111 This original case report applied decellularized
porcine small intestinal submucosa extracellular matrix (SIS-ECM, a biomaterial described and
evaluated for tissue repair by Badylak112) as a scaffold to a severe injury of the quadriceps femoris
muscles, resulting in considerable improvement in peak torque and total work for the affected
limb.
This case report was followed by establishment of standardized mouse and rat models of
VML by the Badylak113 and Walters114 groups which are now the basis of many studies evaluating
15

potential scaffold and cell-based therapies for VML. Implantation of lone decellularized ECM
scaffolds similar to that of the original 2010 case report have been attempted in these models but
have yielded mixed results. Intriguingly, Corona reported that implantation of decellularized
muscle ECM in the rat VML model resulted in significant force recovery without concurrent
myofiber regeneration, potentially due to the implant and resulting fibrotic mass conferring
protection from overloading on the remaining healthy muscle115. A later study examining the
effects of Losartan -an antihypertension medication which has been shown to reduce fibrosis in
regenerating skeletal muscle116,117- on fibrosis and regeneration in rat VML revealed that while
daily Losartan administration from 3 through 28 days post-injury reduced fibrosis, the functional
outcome was a significant decrease in limb force along with no significant evidence of
myogenesis.118 Thus, reducing fibrosis without some other compensating factor present further
impairs muscle function in VML, possibly due to the simple obstacle of the defect to force
transmission.
A specific promising strategy was described by Corona et al in 2013 whereby implantation
autologous minced muscle grafts (MMGs) at the site of injury resulted in the formation of new
myofiber generation and reduced fibrosis, as well as an increase in net isometric torque compared
to unrepaired limbs, though no significance was observed with when torque was normalized to
muscle mass.119 However, the addition of voluntary wheel running following MMG treatment
resulted in a significant increase in muscle mass-normalized isometric torque and decrease in
intramuscular collagen; the concurrent observation of decreased macrophage marker expression
suggested a potential augmentation of the fibrotic response and immune cell involvement in
recovery from VML. Cross-sectional area of new myofibers within the defect area decreased with
the addition of exercise, potentially implicating hypertrophy of surrounding muscle in force
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improvements seen, though this does not appear to have been assessed in that work and free wheel
running does not appear to induce myofiber cross-sectional area in the tibialis anterior of mice120
nor any increase in tibialis anterior mass in rats121.
The foundational rationale for exploring the use of autologous MMGs is that they are
essentially a liberation of myofibers and consequently satellite and other muscle resident cells;
thus, transplantation of additional regeneration-capable cells following wound debridement might
promote regeneration whereas the inflammatory and potentially infected wound environment
immediately following injury and preceding debridement (and thereby a likely disruption of
resident cells) presents an obstacle to regeneration by resident satellite cells. Indeed, devitalization
of MMGs in VML -leaving defect-adjacent cells as the sole source of myogenic precursors- results
in no notable myofiber regeneration, whereas rats treated with unmodified MMGs exhibited
significant myofiber regeneration.122 Further, the amount of autologous donor muscle required for
preparing the MMG can be halved by suspending the preparation in a collagen hydrogel, leading
to a functional outcome similar to that seen when the full MMG mass is used without a carrier.123
Importantly, GFP labeling of MMG donor cells has demonstrated the direct and primary
contribution of these cells to myofiber regeneration following mouse VML, with an average of
284 GFP+ myofibers per tibialis anterior muscle at 28 days post-injury.124 Encouragingly, positive
effects of MMG transplantation in porcine VML have been observed, suggesting the potential
scalability of this approach to the clinic, though MMG transplantation does not yet appear to have
been trialed in human VML.125
The ineffectiveness of devitalized MMGs in promoting muscle regeneration highlights the
difficulties in applying acellular scaffolds to the treatment of VML, despite the positive 2010 case
report. While improved functional outcomes have been seen in the use of acellular scaffolds for
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VML in some small clinical reports126-129, these improvements are generally modest, with
unconvincing evidence of myofiber regeneration and lingering functional deficits compared to
uninjured limbs, implicating fibrosis-mediated improvement in force transmission as the primary
contributor to recovery; this is consistent with reports of a lack of myogenesis during acellular
scaffold treatment of VML in the rat model.130 Clinical reports to date have also tended to involve
interventions taking place months after the initial injury, complicating comparison of functional
outcomes to existing preclinical studies which typically perform repair on the same day as injury;
it is therefore difficult to ascertain the predictive value of the present body of preclinical VML
studies in estimating clinical outcomes of potential therapies. Given that immediate biomaterial
repair of VML is an ideal not realized in the clinic, it may be prudent in to assess promising VML
therapies in animal models with a delayed onset of repair from the time of injury. Such studies will
yield clinically relevant insight into whether promising therapies are able to revive a muscleregenerative program weeks or months after the initial injury when fibrosis of the wound is
complete. Additional clinical study is clearly needed as well, as the cumulative number of VML
patients in clinical reports reviewed here totals only ~22 subjects, with varying sites, degrees, and
manners of injury, though it is recognized that the natural heterogeneity of VML presents
difficulties in acquiring subjects suitable for controlled study.
Griesing et al evaluated two commercially available FDA-approved ECM biomaterials
(SIS and urinary bladder matrix (UBM)) and hyaluronic acid hydrogel in the repair of VML in a
porcine model, assessing both neuromuscular strength and transcriptome profiles by RNAsequencing at 12 weeks post-injury. Notably, repair with SIS or UBM resulted in functional
outcomes equivalent to unrepaired VML, and SIS implantation was observed to result in
substantial inflammation in the days following surgery. While a detailed breakdown of
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overrepresented pathways by treatment group was not presented, unrepaired and repaired muscles
exhibited substantial numbers of unique differentially expressed genes (DEGs), with 499 DEGs
unique to the SIS-treated group alone. Interestingly, there were no significant overrepresented
pathways for the sets of DEGs unique to each treatment group, and PCA analysis revealed
clustering of all VML-injured groups, suggesting that the treatment strategies assessed do not alter
global transcriptome expression in a coordinated manner at 12 weeks post-injury.
Aguilar et al recently performed a somewhat more detailed transcriptome profiling of VML
and autologous minced muscle autograft repair in the rat model across time points ranging from 3
to 14 days post injury. Interestingly, MM repair of VML resulted in a similar transcriptional
trajectory as unrepaired VML, showing a persistent upregulation of inflammation and fibrosisrelated transcripts in response to VML (1925 total DEGs at 3 days post injury to 16 DEGs at 28
days), though a detailed analysis of DEGs in the MM group in comparison to the VML set was not
presented. It is therefore unclear from this work whether there any distinct transcriptional behavior
occurring in the MM treatment group which could contribute to the improved functional outcome
relative to untreated VML. Regardless, it is clear that MM alone does not change the overall
fibrotic fate of the VML wound environment.
An underexplored aspect of VML is how the neuromuscular unit is affected by severe
muscle injury, with what degree ostensibly effective preclinical biomaterial therapies are
modulating peripheral nerve repair remaining largely unclear. It is evident that if substantial injury
occurs to axons and neuromuscular synapses in the largely intact muscle adjacent to a VML injury,
that muscle may atrophy from disuse without timely repair, and whether this is a common
occurrence in VML remains unclear. Corona et al recently advanced this area considerably by
demonstrating that a VML injury ablating 20% of the tibialis anterior in Lewis rats results in a
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disproportionate degree of motoneuron axotomy in the tibialis anterior, with an average of 69% of
motoneurons innervating the tibialis anterior being subjected to axotomy131,132. This finding was
based on pre-surgical and post-surgical labeling by intramuscular injection of Alexafluorconjugated Cholera Toxin Subunit B, which is commonly used as an approach for both retrograde
and anterograde labelling of neurons and their associated axons133. CTB is principally a ligand for
the GM1 ganglioside present on the surface of neurons, which is endocytosed following CTBbinding, allowing for imaging of the entire neuron and axonal tract134,135. Thus, this specific assay
may be a useful indicator of axotomy for future investigations utilizing animal VML models,
though Corona et al did not specify in their publication the exact area of the spinal cord assessed.
The finding of motoneuron axotomy in VML, its correlation with muscle force deficits,
and apparent persistent lack of axon recovery in the weeks following VML injury suggests that
the neuromuscular units of ostensibly intact adjacent muscle tissue are negatively impacted, and
consequently that this neuromuscular disruption has a role in long term VML deficits. It has long
been known that axotomy of muscle-innervating nerves results in significant atrophy of the
formerly innervated muscle tissue136, and therefore a goal of successful VML therapies should be
to address damage to the neuromuscular unit where it occurs, by promoting the regeneration of cut
axons and then formation of functional neuromuscular junctions; the key chemical synapses
mediating the transduction of an action potential into muscle contraction. The general outcomes
of muscle innervation following nerve injury have been studied in some depth in the plantar
muscles such as the tibialis anterior assessed in most preclinical studies, often through crush of the
sciatic nerve, which contains distal branches innervating muscles of the lower limbs.
One proposed approach to accelerating peripheral nerve repair is the application of
electrical stimulation, which has been shown in various animal studies to promote the onset of
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axonal regeneration.137-139 Notably, it has been shown in rats that it is specifically brief low
frequency stimulation (2 Hz) which promotes regeneration, with higher frequencies (200 Hz)
resulting in less regeneration of sciatic nerve following injury.140 Asensio-Pinilla et al
demonstrated that a combination of treadmill running (5 meters per minute for 2 hours daily) with
a one-hour electrical stimulation immediately following injury (3 volts, 20 Hz) resulted in
significantly increased muscle innervation and number of regenerated axons compared to control
rats and those subjected to chronic (1 hour daily) electrical stimulation.141 Further, similar positive
outcomes were observed in a clinical pilot study in which patients undergoing carpal tunnel release
surgery were subjected to an acute electrical stimulation (1 hour, 4-6 volts, 20 Hz) of the median
nerve142; quantification of axonal regeneration by motor unit number estimation (MUNE) revealed
that patients subjected to electrical stimulation following surgery on average exhibited a
remarkable comparable-to-normal innervation at 12 months post-surgery, while patients
undergoing surgery only experience no significant increases in number of motor units when
evaluated 3-12 months post-surgery. Brief electrical stimulation has also been shown to improve
outcomes in recent clinical application toward shoulder dysfunction143, recovery following digital
nerve transection144, as well as reduce pain145. However, the literature is less clear on whether such
an approach would yield similar results when it is the downstream muscle-nerve unit subjected to
direct injury rather than an upstream nerve. In contrast to much of the literature, limited reports
suggest that electrical stimulation can have an adverse effect on the neuromuscular unit in the
plantar muscles146, or may prevent muscle atrophy while not appreciably affection
reinnervation147. The molecular changes potentially mediating the effects of electrical stimulation
have not been extensively characterized, but several studies have observed significant increases in
neurotrophin expression following stimulation, including BDNF and GDNF.148-151. Specifically,
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in vitro evidence suggests that exogenous BDNF promotes neurite outgrowth through activation
of JAK/STAT signaling152 as well as neuron survival153. The general trend of promising preclinical
and clinical outcomes observed in the application of brief electrical stimulation toward restoring
muscle innervation following upstream nerve injury invites preclinical exploration of the approach
as an additional low-risk therapy for VML.
Biomaterials-based approaches to nerve regeneration have been extensively discussed in
the recent neuroregenerative literature.154-159 Nerve grafts are used in the clinical repair of
peripheral nerve injury but, like muscle grafts, involve limited availability and the possibility of
immunological reaction; considerable interest therefore exists in generating synthetic materials to
promote nerve regeneration. Typically taking the form of a polymeric tube which is bridged across
a nerve defect, successful nerve regeneration across defects of 10-30 mm are is well attested.
Greater yet distances have been bridged through the use of collagen sponges, with one study in
dogs indicating successful regeneration across an 80 mm nerve defect.160 While biomaterials
specifically targeting peripheral nerve regeneration in the context of VML are not yet described,
evidence does exist that the class of allogeneic decellularized scaffolds that are commonly assessed
for VML repair may improve muscle innervation following injury.161
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C. Bioengineering Regenerative Materials In Vitro
While decellularized allogeneic and xenogeneic scaffolds are popular for their
demonstrated potential in the repair of several tissues including skeletal muscle, the limited
availability of cadaveric tissue and the potential for immune reaction to foreign epitopes are
limiting factors in their application, particularly toward tissues which are not scar-tolerant or in
which a foreign body reaction could prove fatal; such was the case in the implantation of Synergraft
decellularized porcine heart valves, resulting in the death of three children due to inflammationinduced implant failure and subsequent explantation of the valve from the fourth child.162
A potential alternative for decellularized cadaveric tissues exists in the rapidly developing
field of in vitro tissue engineering. While the prospect of producing whole functioning organs in
vitro remains somewhat elusive, the production of extracellular matrix (ECM) -the foundational
structure of any decellularized cadaveric tissue- in vitro is an existing technology. However,
typical ECM production involves the culture of cell monolayers and the gentle mechanical or
enzymatic dissociation of the cell/ECM sheet from its substrate163,164. Alternatively, a promising
approach enabled by advances in material science in the past decades is the development of cell
culture systems using temperature-responsive polymers as the cell substrate. Poly(Nisopropylacrylamide) (NIPAAM) is a polymer which dissolves in water below 32 °C due to
conformational changes induced in the polymer chain induced by hydration165; Yamada and Okano
et al demonstrated that this property allowed for deadhesion of hepatocytes from a NIPAAMgrafted polystyrene surface.166 Interestingly, cells generally do not adhere efficiently to thick (>30
nm) layers of NIPAAM due to insufficient dehydration of polymer chains, resulting in insufficient
hydrophobicity for cell adhesion.167 Thus, constructs for thermally responsive deadhesion of cells
and ECM typically use nanoscale layers of NIPAAM grafted to existing cell culture surfaces.
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Regardless of substrate composition or method of ECM retrieval, conventional 2D culture
has significant limitations in the retrieval of cell products. Principally, the relatively low surface
area of flat culture flasks results in a low adherent cell density and protein productivity relative to
that exhibited in suspension culture. For example, a typical 75 cm2 cell culture flask may achieve
approximately 100,000 cells/cm2, utterly dwarfed by the extreme cell densities achievable (in
excess of 100*106 cells/mL) with suspension culture of the Chinese hamster ovary (CHO) cells
currently used for 70% of industrial antibody production168. While it is intuitive that adherent cell
systems are inherently less productive than suspension culture, most cell types of tissue
engineering interest are anchorage-dependent, and bioreactor systems now exist which leverage
high surface area substrates to maximize cell density and productivity.
Among the most productive of these is the hollow fiber bioreactor. Knazek et al described
in 1972 the culture of fibroblasts on cellulose acetate capillaries, yielding 1 mm diameter growths
following 28 days of incubation; the authors remarked the high cell densities culturable in a such
a high surface area-to-volume-ratio system and thus the potential to engineer tissues in vitro.169 In
the decades since, hollow fiber membrane-based bioreactor systems have seen commercial
application for the production of monoclonal antibodies in addition to their ubiquitous application
in industrial separations processes. Hollow fibers are attractive as cell culture substrates due to
their high surface area, tunable pore diameters governing their transport properties, and a wide
range of materials allowing one to tailor the substrate properties for cell proliferation and survival.
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Figure 3: Example of a Simple Hollow Fiber Membrane Bioreactor
The typical hollow fiber membrane bioreactor (Figure 3, example by author) takes the
form of a cylindrical cartridge in which rest hundreds of individual hollow fibers sealed at each
end by a biocompatible resin, with anchorage-dependent mammalian cells cultured on the outer
surfaces of the membranes and medium pumped through the extracapillary space of the
cartridge. While the assembly of such a bioreactor seems in principle relatively straightforward,
the choice of membrane substrate, perfusion rate, atmospheric conditions, fiber spacing170, and
cartridge material have significant effects on cell survival, proliferation, and productivity.
Hollow fiber bioreactor development is an active area of private development, with several
recent patents on the matter171-174 and commercial availability of ready-to-use bioreactor systems
such as those produced by FiberCell Systems, with surface areas of up to 1.2 m2 and
corresponding cell densities of up to 5.0E10 cells in a single 60 mL cartridge175.
Hollow fiber bioreactors have been of interest for use in tissue production as artificial
organs since the early investigations into the scalability of hollow fiber cell culture and modeling
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of their transport properties.176-178 In the context of ECM production, Potter et al demonstrated
the ability to grow 1 mm-thick masses of cartilage179 after four weeks of culturing embryonic
chick chondrocytes in a hollow fiber bioreactor system, with development of tissue monitored by
MRI. Oxygen transport is considered to be the most limiting factor in the bioreactor culture of
mammalian cells, including within the hollow fiber bioreactor.180 For example, when a
membrane-anchored biofilm grows -as with the development of cartilage in the Potter study- the
diffusive transport of oxygen and key medium nutrients across the membrane is hindered. Given
the short distances across which solely diffusive transport of oxygen across tissues is relevant
(~1 mm)181, the addition of convective transport of oxygen is critical182, as illustrated by Ku et
al’s observation that as much as much as 25% of the dissolved oxygen in fresh medium is
consumed as it is perfused through a hollow fiber bioreactor.176
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D. Fabrication, Tuning, and Characterization of Hollow Fiber Membranes
Hollow fiber membranes are ubiquitous in industrial separations for their ability to separate
components of various streams based on size exclusion via layers of selective pores, with an
application of transmembrane pressure and concentration gradients being the primary driving
forces for permeation through the membrane. Hollow fibers commonly manifest as the asymmetric
type, characterized by an exofacial layer of pores and a lumen-facing layer of pores bridged by a
sponge-like support layer, as visible in this example of a NIPS polysulfone hollow fiber membrane
fabricated by the author (Figure, 2 scale-bar = 100 µm). Hollow fibers are engineered via a tunable
process known as phase inversion. Phase inversion is a process which leads to the phase transition
of a polymer solution from liquid to solid, precipitating a porous membrane.183 It is one of the most
prominent methods of membrane fabrication and can occur by several distinct mechanisms; these
include nonsolvent-induced phase separation (NIPS), thermally induced phase separation (TIPS),
evaporation-induced phase separation (EIPS) and vapor-induced phase separation (VIPS). NIPSdriven phase inversion occurs by exchange of nonsolvent for solvent upon immersion of a polymer
solution in nonsolvent, while TIPS causes phase separation by extrusion of a heated polymer
preparation into a cooling bath.184-187 VIPS can be considered a special case of the NIPS
mechanism, wherein the nonsolvent used is in the vapor phase.188,189 Specific manufacturing
processes can exploit combinations of these mechanisms to varying degrees. One of the more
accessible processes is wet spinning, a form of hollow fiber fabrication based on the NIPS
mechanism.
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Figure 2: Example SEM micrograph of a NIPS-Cast Hollow Fiber Membrane
Wet spinning involves the extrusion of dope (polymer) and bore solutions through a
spinneret, after which the combined streams enter an external coagulant (usually water), leading
to the precipitation of a solid hollow fiber membrane by phase inversion; it is thus analogous to
the immersion precipitation process for fabricating flat membranes. There is frequently an “air
gap” between the outlet of the spinneret and the surface of the external coagulant; when an air
gap is used, the process is termed dry-jet wet spinning. The phase inversion process begins
immediately upon exit of the two streams from the spinneret, first primarily by evaporation of
the solvent (if an air gap is present) and then by bulk exchange of solvent and nonsolvent (NIPSdriven) or cooling of a heated polymer dope (TIPS-driven) as the nascent fiber enters the
coagulant bath. Extrusion can be achieved either through the use of pumps or a pressurized inert
gas, wherein the pressures required for extrusion differ depending on factors such as the
viscosity of the dope and bore solutions, as well as the dimensions of the spinneret.
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Performance of hollow fiber membranes in size exclusion separations is often expressed in
terms of a molecular weight cut-off (MWCO). The MWCO of a membrane is generally defined as
the molecular weight of a compound in solution for which a membrane would reject greater than
90%.190 Ultimately, the relation between molecular weight and rejection is only an approximation
for which there are many exceptions, as rejection also depends on the specific structure and
electrostatic characteristics of molecules; this is elegantly illustrated by the fact that relatively large
plasmids can be transported through ultrafiltration membranes via elongation as they converge on
pores, a result that would not be expected if molecular weight were the principal factor.191 Despite
this, MWCO is a useful property when used in reference to a common class of molecules, and is a
ubiquitously reported property of membranes intended for protein separations. Determination of
MWCO is often accomplished by evaluating the membrane separation of polyethylene glycols of
varying molecular weight.192,193 While MWCO provides a practical rule of thumb for the end user,
analysis of membrane structure and composition are necessary for a predicting and tuning
membrane performance during research and development.
The dimensions, distributions, and frequencies of pores dictate the size exclusion properties
of a membrane. In a biopharmaceutical context, membranes of several different nominal pore sizes
are used at different stages of separation, in part to prevent unnecessary fouling of highly selective
membranes by large debris removable by less selective membranes. Microfiltration membranes
(0.1 – 1 µm pores) or microsieves are commonly used to remove bacteria from a stream, while
ultrafiltration membranes (1-100 nm) can be used to effectively separate viruses and high
molecular weight components for purification of protein. Adsorption of protein within or adjacent
to membrane pores is a common challenge in biological separations and is best prevented by using
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a membrane least prone to fouling in the specific application. Thus, characterizing and tuning pore
size distribution are critical aspects of membrane design.
Scanning electron microscopy (SEM) is sometimes used to observe pore size, but comes
with several important caveats. Most importantly, SEM generally assesses a very small area of
sample which may not be representative of the whole. Further, these analyses are most commonly
made based on surface level images, and so the pore diameter determined by the investigator is
typically of the pore opening rather then the pore throat that is most relevant to transport.
Additionally, a more minor consideration is that the sputter-coating process for preparation of
SEM samples may result in a smaller apparent pore size, though this is most relevant in the case
of nanofiltration pores (<10 nm). Mercury porosimetry has been used for decades for determining
the pore size distribution of a great variety of materials, including membranes. It is based on an
inverse relation between the pressure required to push mercury into a pore and the size of that pore,
as described by a modified form of the Young-Laplace equation referred to as the Washburn
equation. However, there are several important caveats to consider regarding the use of this
technique for membranes; first, the high pressures required to force mercury through a membrane
may damage the membrane and thus alter its pore size distribution. Secondly, mercury porosimetry
does not measure the most constricted portion of a pore channel; rather it determines the diameter
of the pore’s entrance, which is not as important to transport as the former property. It also does
not distinguish between dead-end pores (which do not function in size exclusion) and continuous
pores. Further, the instrumentation –while readily available from several commercial sources- can
be quite expensive compared to alternative techniques. However, mercury porosimetry does have
the advantage of being rapid and applicable across a relatively wide pore size range.
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LLDP is an attractive technique for the measurement of ultrafiltration membrane pores, as
it uses relatively low pressures compared to those required for mercury intrusion, avoiding
compaction of membranes that could produce erroneous results, and generally measures the
diameter of the continuous pores that are relevant to transport.194 Further, it also evaluates the
membranes while wetted, as they might be under operating conditions.195 LLDP operates through
the displacement of a wetting liquid in the membrane by a “displacing” liquid. As pressure is
increased stepwise, the Hagen–Poiseuille equation can be used to generate a pore size distribution
based on flux of displaced water.196 Another useful aspect of LLDP is that it can be used to estimate
the molecular weight cutoff (MWCO) of ultrafiltration membranes, as described by Calvo et al.197
Despite the utility of LLDP, any interactions between the liquids used and the membrane that may
affect its pore size distribution (e.g., swelling) must be considered.198
Nitrogen adsorption-desorption is generally considered the gold-standard technique for
analysis of surface area and pore diameter, with widely available commercial equipment. In 1938
Brunauer, Emmet, and Teller published their method for relating the adsorption of gas to the
surface area of the adsorbent.199 Though the theory is based on the Langmuir model of adsorption
which makes the assumption that the adsorbent is of a planar geometry200, the BET theory remains
the industrial standard for determination of surface area. In 1951 Barrett, Joyner, and Halenda
described a procedure (BJH) for relating gas adsorption to pore diameter based on the Kelvin
equation.201 It is remains commonly used, but is criticized for resulting in high error as nominal
pore size decreases.
Despite various advantages of the aforementioned techniques -including their broad use in
literature enabling convenient comparison- common to all of them is the necessity of fairly
specialized and expensive equipment which may not be accessible to investigators interested in
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pore diameter who are not specialists in pore characterization. Evapoporometry is a novel method
for calculation of pore diameter distribution which relates the instantaneous evaporation rate of a
fluid from a saturated sample to the diameter of instantaneously draining pores via a derivation of
the Kelvin equation:
𝑑= −

4𝑦𝑉
𝑊
𝑅𝑇𝑙𝑛 𝐴0
°
𝑊𝐴0

where 𝑦 is surface tension, V is vapor molar volume, R is the universal gas constant, T is absolute
°
temperature, 𝑊𝐴0 is the instantaneous evaporation rate and 𝑊𝐴0
is the average rate of evaporation

for a layer of the volatile fluid initially overlying the sample. Evapoporometry is most notable for
the fact that it requires only materials that are ubiquitous in most engineering laboratories: an
analytical balance with a 10 µg resolution and PC interface, a PTFE test cell in which to secure a
fluid saturated sample, and a volatile fluid of choice. Evaporative mass loss is to molar evaporation
°
rate (𝑊𝐴0 and 𝑊𝐴0
) and used with surface tension (of the fluid), vapor molar volume, and absolute

temperature to yield the pore diameter in meters for pores draining at a particular instant.
Importantly, evaporation proceeds in descending order of pore size due to supersaturation of vapor
for all pores smaller than those draining at any instant. However, the method incurs some
limitations, chiefly an upper limit of pore detection of ~300 nm202, the possibility of fluid-sample
interactions, and an unstandardized graphical analysis approach for data analysis which has in
practice lead to considerable user-to-user variation in analysis of identical datasets. Further, the
method has largely been validated with idealized flat sheet membranes with well defined pores,
and it remains whether the precision of the technique is maintained when used for more irregular
samples such as solvent-cast membranes or ion exchange resins. Finally, given the known
relationship between pore diameter and surface area, there is expected to be a proportionality
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between evaporated mass and surface area, but this has not been specifically evaluated in the
literature. A software-aided approach to address challenges in evapoporometry data analysis is
discussed in chapter 4.
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E. Objective
The primary objectives of this work are threefold: to evaluate the feasibility of a sacrificial
hollow fiber membrane cell culture approach for the production of matrix scaffolds targeted toward
VML, improve the methodology for characterizing the dimensions of pores influencing the
performance of membranes in industrial separations and cell culture, and to develop a better
understanding of the biomolecular processes mediating recovery in biomaterial-based repair of
VML.
We first demonstrate the isolation of bulk threads of ECM in vitro through the intraluminal
seeding of ECM-productive mammalian cells in solvent-degradable hollow fiber membranes. We
further characterize the mechanical and biochemical properties of ECM isolated from sacrificial
scaffolds, demonstrate its assembly into implantable meshes, and show that it supports the viability
of mammalian cells in vitro. We additionally provide a separate detailed description of methods
for producing bulk ECM by this approach, from membrane fabrication through implant processing.
In the interest of increasing the accessibility of pore dimension analysis beyond the
membrane specialist, we develop an open-source Python GUI tool for the analysis of
Evapoporometry data. We show that software-aided analysis yields precise analysis of pore
diameter for well-characterized membranes as well as ion exchange resin, in agreement with
analysis by gold-standard methods. We further demonstrate the initial application of this method
for evaluating relative differences in surface area.
Finally, we perform the first transcriptomic analysis by RNA-sequencing of a combined
decellularized skeletal muscle (DSM) plus autologous minced muscle (MM) VML repair approach
which in our previous work has been shown to restore over 50% of muscle contractile force lost
to VML in a rat model.203 We demonstrate that the primary patterns of gene expression correlating

34

with force recovery in the two-week period following injury are primarily of a neuroregenerative
nature, with significant implications for future VML research.
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Abstract
The therapeutic potential of biological scaffolds as adjuncts to synthetic polymers motivates
the engineering of fibers formed using the extracellular matrix (ECM) secreted by cells. To
capture the ECM secreted by cells during in vitro culture, a solvent degradable hollow fiber
membrane (HFM) was created and utilized as a cell culture platform. 3T3 fibroblasts were
injected into the narrow (0.986 ± 0.042 mm) lumina of mesoporous polysulfone HFMs and
maintained in culture for up to three weeks. Following cell culture, HFMs were dissolved
using N-methyl-2-pyrrolidone (NMP) and the accumulated ECM was collected. The ECM
retained the filamentous dimensions of the HFM lumen. The process yielded up to 0.89 ± 0.20
mg of ECM for every mm of HFM dissolved. Immunofluorescence, second-harmonic
generation microscopy, and tandem mass spectrometry indicated the presence of an array of
ECM constituents, including collagen, fibronectin, and proteoglycans, while FTIR spectra
suggested thorough HFM material dissolution. Isolated ECM fibers, although fragile, were
amenable to handling and exhibited an average elastic modulus of 34.6 ± 15.3 kPa, ultimate
tensile strength of 5.2 ± 2.2 kPa, and elongation-at-break of 29% ± 18%. ECM fibers
consisted of an interconnected yet porous (32.7% ± 5.8% open space) network which
supported the attachment and in vitro proliferation of mammalian cells. ECM fibers were
similarly synthesized using muscle and astrocyte cells, suggesting process robustness across
different cell types. Ultimately, these ECM fibers could be utilized as an alternative to
synthetics for the manufacture of woven meshes targeting wound healing or regenerative
medicine applications.
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A. Introduction
Woven surgical meshes are extensively utilized for the repair of damaged tissues. Each
year over 1 million surgical meshes are implanted worldwide1. These meshes are typically
fabricated using synthetic polymer fibers, the most common being polypropylene. Biomaterial
fibers are highly versatile materials that can be woven into a range of implant geometries
(meshes, tubes, ropes) using high throughput fabrication methods developed and routinely used
by the textiles industry. However, the dramatic rise in the use of surgical meshes has been
matched by a similar rise in serious post-surgical complications and product recalls2-4. The
complications associated with surgical meshes appear to be a direct consequence of the host
response to synthetic polymer implants5. Specifically, the aggressive foreign body response,
characterized by fibrotic tissue formation combined with the chronic activation of immune cells
at the site of implantation, appears to be a serious roadblock to clinical success6. In fact, the
aggressive fibrotic response directed against implanted synthetic materials requires that surgical
meshes be applied only where scarring at the site of implantation can be tolerated. For instance,
in cases where woven meshes are used to repair hernias the dense scarring response strengthens
the repair site7. However, for many regenerative applications (muscle, vessel, nerve), the
restoration of native tissue structure is the goal, and therefore the disorganized scarring
associated with the foreign body response is a severe disadvantage. Ultimately, while fibers
have tremendous potential as the raw material for biomedical implants, synthetic polymer fibers
are unlikely to find clinical utility for the repair of non-connective tissue types. For cardiac,
vascular, nervous, and muscle tissue repair, the need exists for a biomaterial fiber that can be
remodeled by the body’s own wound healing machinery.
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Extracellular matrix (ECM) is a network of biomolecules secreted by all somatic cells of the
body which functions as both a physical support for tissues and a reservoir of chemical cues
which guide cell differentiation, migration, and tissue remodeling8. ECM is noted for its
regenerative capacity, with several clinical studies having demonstrated the efficacy of ECMbased grafts for repair of heart, skin, cartilage, and other tissues9-12. Of particular relevance to
woven meshes, published evidence suggests that fibers containing extracellular matrix (ECM)
molecules mute the foreign body reaction and enhance regeneration13,14. Specifically, Badylak
and colleagues have shown that ECM-coated synthetic meshes reduced the fraction of proinflammatory M1 macrophages at the site of implantation and that this change enhanced tissue
remodeling. However, while composite ECM/synthetic fibers may delay a foreign body
response, they are unlikely to eliminate it completely. As the ECM degrades and the underlying
synthetic material interface is exposed to the immune system, a foreign body reaction will
eventually be initiated. We suggest that fiber built entirely from ECM -carrying an arsenal of
macromolecules relevant to wound-healing-is a logical next step toward the development of
whole ECM meshes which may have clinical utility as an adjunct to synthetic polymers.
To create ECM fibers, our group has previously explored methods to farm the ECM
secreted by populations of mammalian cells during growth in culture15,16. The creation of ECM
fibers is predicated by a simple principle; cells have the ability to produce ECM, and the
primary challenge is to develop methods to concentrate and collect the molecules that they
secrete. Toward this end, we have explored a technique to facilitate the accumulation of
cellsecreted molecules using hollow fiber membranes (HFMs) as a cell culture platform. When
the lumen is seeded with cells, the semipermeable HFMs trap the large cells and secreted ECM
molecules, but permit the exchange of smaller cell culture nutrients. The application of HFM’s
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for cell culture is not unique by itself, semipermeable HFM’s have been used as platforms for
the cultivation, implantation, and immuno-isolation of hepatocytes and pancreatic islet cells17,18.
What is unique is the sacrificial role of the HFM. Rather than being a permanent component, it
instead serves as a temporary platform used to capture and collect cell secreted ECM. Once
sufficient ECM has been collected, the synthetic HFM can be dissolved, leaving behind only the
accumulated ECM which retains the shape of the lumen. In this study, we describe this novel
scheme for the production of ECM fibers using sacrificial HFMs as a cell culture platform, and
present the characterization results for several key ECM fiber physical and chemical properties.
B. Materials and Methods
Preparation of Hollow Fiber Membranes
Mesoporous polysulfone HFMs were manufactured using a common dry-jet wet spinning
method19 (Table 1). Polysulfone pellets (35kD, Sigma, St. Louis MO) were dissolved in Nmethyl-2-pyrrolidone (NMP, 17.8 w/w%) for three days at 25 °C. Polysulfone (PSF) dope
solution and a bore solution of NMP in deionized water (15, w/w%) were extruded through a
spinneret (AEI) using pressurized N2. Flow of dope and bore solutions from the spinneret into
an air gap and subsequent water bath resulted in precipitation of polysulfone fibers by
nonsolvent-induced phase separation (Figure. 1). HFMs were stored in deionized water for three
days, with water exchanged once per day for removal of residual solvent.
Cell Culture
To facilitate cell culture, HFMs were sterilized in 70% ethanol for 24 hours and incubated in a
solution of bovine plasma fibronectin (20 μg/mL) at 37 °C for one hour, after which they were
cut using sterile scissors to lengths of 6 cm for cell-seeding. Frozen NIH/3T3 fibroblasts
(ATCC, Manassas, VA), suspensions were thawed, seeded into T-175 flasks, and cultured until
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confluent in DMEM/F12 containing 10% (w/v) fetal-bovine serum (FBS), 1% L-glutamine, and
1% penicillin-streptomycin. Confluent cultures were disassociated using 0.25% Trypsin-EDTA
prior to centrifugation. Pellets were resuspended in DMEM/F12, with cell density counted using
a hemocytometer. Cells were seeded into the lumina of HFMs at a density of approximately
20K cells/cm of fiber length using a sterile 21-gauge needle and syringe.
All cell seeded HFMs were cultured for durations of either one or three weeks in
DMEM/F12 supplemented 10% (w/v) FBS, 1% L-glutamine, 1% penicillin-streptomycin, 0.285
mM L-ascorbic acid (Sigma), 0.5 mM L-ascorbic acid 2-phosphate (Sigma), and 5 ng/mL
human TGF-β1 (Peprotech, Rocky Hill, NJ). At the completion of the culture period, cellseeded HFMs were dissolved in 99.5% NMP for three days, with NMP exchanged once per
day. The remaining cell-derived material (ECM fiber) was collected, rinsed for 48 hours in DI
water, and characterized. A subset of HFMs were seeded and cultivated with rat astrocyte and
skeletal muscle fibroblast cells to evaluate process robustness across cell types. Astrocyte and
muscle cells were harvested via methods approved by the University of Arkansas Institutional
Animal Care and Use Committee (IACUC).
Characterization
Transverse cross-sections of naïve polysulfone HFMs were fractured in liquid nitrogen
and imaged by SEM to visualize membrane morphology. HFM inner diameter, outer diameter,
and wall thickness were measured from microscope images collected from representative
samples (n =10). The pore-size distributions of HFMs were determined using evapoporometry
and guided by published protocols20–22. HFMs were fixed to plastic test cells (n = 3) using an
epoxy resin, immersed in 99.5% isopropanol, and mass loss due to evaporation of isopropanol
was measured for 24 hours, from which pore-size distributions were calculated using equations
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described by Krantz et al22. Evapoporometry was chosen as the technique for probing pore size
in this investigation, as it avoids the application of significant pressure to a sample, is nondestructive, and has been applied successfully toward the analysis of the selective layers of
pores between 4 nm to 365 nm in asymmetric membranes, including hollow fiber membranes
similar to those produced in this investigation23, 24.
The effectiveness of the NMP dissolution method was assessed using attenuated total
reflectance Fourier transform infrared spectroscopy (ATR-FTIR) with a resolution of 8 cm−1
and a scanning range of 900–1800 cm−1. ATR-FTIR spectra for representative NIH/3T3
derived ECM fibers, cultured polysulfone HFMs, and naive HFMs were analyzed for the
presence of sulfonyl groups and aromatics characteristic of polysulfone, as well as protein
characteristic amide bands.
In preparation for characterization, NIH/3T3 derived ECM fibers were decellularized
using a detergent based protocol25. Samples were rinsed for 90 min in Tris-HCL (10mM,
pH8.0) with 1% EDTA and 10KU/ml aprotinin 4°C with agitation. Samples were then soaked
in 0.1% sodium dodecyl sulphate (SDS) in Tris-HCL buffer for 24 hours at room temperature
with agitation. To remove nuclear remnants samples were then incubated for 3 h in reaction
buffer containing 50U/mL deoxyribonuclease I and 1U/mL ribonuclease A in 10mM TrisHCl
(pH 7.5) at 37°C with agitation. To assess decellularization effectiveness, treated and control
samples (n=3/sample group) were fluorescently stained for the presence of the cytoskeletal
protein actin using phalloidin (1:40, Sigma). Cells were counterstained with the nuclear reagent
DAPI. Representative decellularized material samples were imaged for comparison to cellcontaining controls.
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Decellularized NIH/3T3 derived ECM fibers were rinsed in deionized water and weighed.
Yields were calculated relative to HFM length (mg/mm). Astrocyte and muscle cell derived
ECM fiber yield was similarly measured. To examine the internal structure, hydrated NIH/3T3
ECM fiber samples (n=3) were sectioned (7 μm) with the aid of a cryostat (Leica), mounted
onto microscopic slides, stained with hematoxylin and eosin and imaged. From the digital
images, the porosity (% open area) was calculated from transverse ECM fiber sections with the
aid of image analysis software (ImageJ), through subtraction of freehandbounded pore area
from total section area and dividing the difference by total section area to yield porosity. To
visualize fiber surface features, NIH/3T3 derived fiber samples were frozen, lyophilized, and
imaged using scanning electron microscopy (SEM). The SEM imaging of lyophilized samples
was motivated by the anticipated use of freeze-drying to prepare materials for storage and
implantation.
HFM and decellularized NIH/3T3 ECM fiber mechanical properties were measured with
the aid of a uni-axial mechanical testing device (5994, Instron, Norwood, MA) using techniques
familiar to our group16, 26, 27. Hydrated (PBS, pH = 7.4) samples (gauge length = 1 cm) were
deformed at a constant strain rate of 10%/min until failure using a 1N load cell while load and
displacement values were recorded at 10 Hz. Prior to testing, sample (n = 4/sample group) fiber
diameter was measured using digital calipers. For each sample, engineering stress versus strain
curves were generated from load and elongation data. Strain was determined using grip
displacement values. From each curve, the tangent modulus was calculated using a linear fit to
the region of the stress-strain curve extending from the end of the toe in region, approximately
10% and 0.5% strain for ECM and HFM fibers respectively, to the point of sample failure. The
ultimate strength was calculated as the peak stress achieved by each fiber prior to failure.
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NIH/3T3 ECM fibers were assessed for the presence of accumulated ECM constituent
proteins by immunofluorescence. Representative fibers were immunoreacted for the presence of
cellular fibronectin (Mouse IgM, 1:500, Sigma) followed by the appropriate fluorescently
labeled secondaries (1:500, Alexafluor, Life Technologies). Samples were counterstained with
the nuclear staining reagent DAPI, and then microscopically imaged using an Eclipse Ci-S
microscope with D-FL epifluorescence attachment (Nikon, Tokyo, Japan). The accumulation of
organized fibrillary collagen within ECM fiber samples was assessed using label free second
harmonic generation microscopy (Ultima Investigator, Bruker Inc., Middleton, WI) [25].
NIH/3T3 ECM fiber proteomic composition was further assessed using tandem mass
spectrometry (MS/MS). MS/MS was performed with the aid of the University of Arkansas for
Medical Sciences proteomics core facility. Samples were hydrated in acetonitrile, digested with
trypsin in 100 mM ammonium bicarbonate at 37°C for 12–16 hours. Tryptic peptides were
separated by reverse phase Jupiter Proteo resin (Phenomenex) on a 200 × 0.075 mm column
using a nanoAcquity UPLC system (Waters). Eluted peptides were ionized by electrospray
(2.15kV) followed by MS/MS analysis using higher-energy collisional dissociation (HCD) on
an Orbitrap Fusion Tribrid mass spectrometer (Thermo Scientific, Waltham, MA) in top-speed
data-dependent mode. Proteins were identified by comparison to a proteomics database
(Mascot, Matrix Science). Scaffold proteomics software was used to verify MS/MS protein
identification, with identifications accepted if established with a less than 1% false discovery
rate as determined by Scaffold’s local FDR algorithm.
A direct contact assay was employed to assess cellular attachment and proliferation upon
ECM fiber materials. In preparation for cytotoxicity assays, decellularized NIH/3T3 ECM
fibers (approximate length = 1cm) and unmodified glass coverslips (n = 3/sample group) were
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sterilized for 24 hours in 70% ethanol. NIH/3T3 cells were seeded onto each sample at a density
of 10 K cells per sample, and cultured in DMEM-F12 with 10% (w/v) FBS, 1% L-glutamine,
and 1% penicillin-streptomycin. Following 72 hours of culture, samples were assayed for cell
viability and death via Calcein AM (2 μM in PBS) and EthD-1 (4μM in PBS), respectively.
Calcein stained ECM fibers were microscopically imaged and assessed for cell coverage.
In vivo host response was examined using a subcutaneous implant site. In vivo
biocompatibility was assayed at 2 and 6 weeks post-implantation time points. Mature male
Sprague Dawley rats (300+g) were used (Envigo, IN). All surgical procedures were performed
in accordance with protocols approved by the University of Arkansas Institutional Animal Care
and Use Committee. Anesthesia was induced using isoflurane (2–4%) in oxygen. The
subcutaneous implant site was surgically exposed through a 2 cm left-right incision placed
caudal to the scapulae. A subcutaneous pouch was created in each animal by blunt dissection. A
single NIH/3T3 ECM sample was implanted into each pouch (approximate implant size 10mm
diameter). Incisions were closed using surgical adhesive (VetBond, 3M). Following surgery all
animals were housed in the University of Arkansas Central Laboratory Animal Facility. At the
prescribed time-points all animals (n=3/ timepoint) were euthanized via inhalation of carbon
dioxide. The implant site with surrounding soft tissue was harvested, fixed in 4%
paraformaldehyde, paraffin embedded, sectioned (10um), and stained with H&E. Stained
sections were imaged and examined for evidence of inflammation and material degradation.
Statistical Methods
All data are represented as mean and standard deviation. The effect of cell type and culture
duration on ECM fiber yield was evaluated with a two-way ANOVA with interaction term. Post
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hoc comparisons were made using Tukey’s test. A standard 0.05 level of significance was used
for all statistical tests.
C. Results
Hollow fiber membranes (HFMs) fabricated by the dry-jet wet spinning technique (Fig. 1) were
of the asymmetric type, with selective inner and outer skin layers supported by a highly porous
intermediate layer (Figure. 2). Approximately 100 meters of HFM were fabricated from 300 mL
of 17.8 w/w% polysulfone in N-methyl-2-pyrrolidone. Evapoporometry analysis of the HFMs
revealed a mesoporous pore size distribution, with an average pore diameter of 39.8 nm ± 3.9
nm. HFM geometry was consistent both within and between batches, with average inner and
outer diameters of 0.986 mm ± 0.042 mm and 1.29 mm ± 0.038 mm, respectively.
Material harvested from HFMs cultured with NIH/3T3 fibroblasts, rat skeletal muscle
fibroblasts (RSMF), and astrocytes was translucent, showed no visual evidence of residual
HFM, and exhibited a continuous filament geometry similar to the diameter and length of the
HFMs in which they were cultured (Figure. 3). Fibers were amenable to handling and could be
woven into a simple crosshatch pattern in a manner consistent with traditional fiber weaving
techniques. HFMs cultured with NIH/3T3 cells for three weeks yielded just under one
milligram (0.89 ± 0.2 mg/mm) of ECM fiber for every mm of HFM seeded. Although still
capable of producing continuous fibers, both skeletal muscle fibroblasts and astrocyte cells
yielded significantly less ECM fiber material (0.44± 0.08 and 0.41± 0.04 mg/mm respectively).
ECM fiber yield was sensitive to culture duration. 3T3 cells exhibited a 4- fold increase in ECM
yield for three weeks versus one week of culture (p = 0.0134). Corresponding increases in yield
for skeletal muscle fibroblasts and astrocytes were 2- fold (p = 0.6965) and 4-fold (p= 0.5316),
respectively.
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Transverse and longitudinal sections of NIH/3T3 ECM fibers (7 μm thickness) revealed a
porous yet interconnected network of eosin stained ECM (Figure. 4). ECM fibers exhibited
open-cell pores distributed irregularly throughout the sections. Analysis of transverse sections
indicated an average interior ECM fiber porosity of 32.7% ± 5.8%. SEM images of lyophilized
NIH/3T3 ECM fibers revealed a dense surface skin with a rough filamentous texture that is
consistent with the appearance of native tissue ECM. The surface skin also showed evidence of
fibril alignment along the longitudinal axis of the ECM fiber. Residual HFM material was not
observed.
ATR-FTIR spectra of NIH/3T3 ECM fibers revealed strong absorbance at 1650 cm−1 and
1540 cm−1, consistent with the amide I and II absorbance bands characteristic of proteins
(Figure 5)28. Comparison of the spectra of isolated ECM fibers to the spectra of cultured and
uncultured polysulfone HFMs indicated that the characteristic polysulfone absorbance peaks
(1580, 1480, 1236, and 1150 cm−1) were not present in the ECM fiber samples, suggesting
effective dissolution of the polysulfone HFM via NMP incubation.
Mechanical testing of HFMs (Figure 6) yielded an average elastic modulus of 10.0 MPa ±
1.82 MPa and an average ultimate strength of 0.717 MPa ± 0.124 MPa. Stress-strain curves for
HFMs exhibited linear elastic regions followed by small plastic regions and sharp failure.
HFMs stretched to an average of strain of 13% prior to failure. Stress-strain curves for
decellularized NIH/3T3 ECM fibers consistently exhibited toe-in regions, typically extending
out to 10%, followed by a near linear increase in stress until failure. No significant plastic
region was observed. The average elastic modulus and ultimate strength for ECM fibers
measured within the linear region were 34.6 ± 15.3 kPa and 5.2 ± 2.2 kPa respectively. On
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average, ECM fibers stretched 29% ± 18% in length before failure. The accumulated ECM
fibers were notably less stiff and more extensible than the once present HFM scaffolds.
Isolated NIH/3T3 ECM fibers were strongly reactive to antibodies directed against
fibronectin (Figure 7). Second harmonic generation imaging also indicated the presence of
fibrillary collagen throughout the ECM fibers. MS/MS proteomic analysis identified an array of
ECM structural components (Table 2), including collagen I, III, VI, XVIII, fibronectin, fibrillin
1, fibulin 1 and 2, and prolargin. Several matricellular proteins were also present, including
EFEMP 1 and 2, thrombospondin 1 and 2, tenascin, and periostin. A complement of
proteoglycans was identified as well, including biglycan, decorin, glypican 1 and 6, and
versican. Pre-decellularization samples were strongly reactive to phalloidin and DAPI staining,
while post-decellularization samples exhibited no specific staining. The gross appearance and
handling of ECM fibers was not significantly altered by decellularization, as fibers remained
continuous and amenable to handling. When reseeded with cells, the NIH/3T3 ECM fibers
supported the attachment and recultivation of NIH/3T3 fibroblasts. Calcein AM staining
directed against NIH/3T3 cells indicated that viable cells were distributed densely across the
surface of the cultured fibers, reaching confluency within 72 hours (Figure 8). EthD-1 staining
indicated a negligible quantity of non-viable cells. No pre-culture treatments (e.g. incubation
with fibronectin) were required for adhesion of cells to the ECM fibers.
All implanted animals tolerated the implantation surgery well and gained weight
throughout the observation period at a rate (8±2 grams/week) that was not significantly different
from un-implanted controls (9±2 grams/week). At 2 weeks post implantation, samples were
well incorporated into the surrounding tissue and host cells had densely penetrated the material
(Figure 8). There was no evidence of a dense fibrous encapsulation layer surrounding the
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implants, nor a necrotic region within it. By 6 weeks post implantation, implant sites showed
evidence of elevated cellularity, but it was sharply reduced when compared to 2 week samples,
suggesting ongoing implant degradation. There was no evidence of local toxicity nor was there
any evidence of multinuclear giant cell formation in regions surrounding the implants at either
timepoint.
D. Discussion
In this study, we have developed a process for extracting whole threads of ECM secreted
by cells cultured in the lumina of sacrificial HFMs. Our findings suggest that this HFM culture
approach is amenable toward the production of filaments of ECM from several cell types, and
that these filaments have a composition and structure that may find utility for the repair of
fibrous tissues in the form of a surgical mesh. The operating principle of the sacrificial HFM
culture method is that ECM produced by cells cultured in the lumina of HFM’s can be captured
and concentrated by preventing cross-membrane transport of ECM constituents. To our
knowledge, this study represents the first time in literature that culture of cells in the lumen of
HFMs has been leveraged for the production and extraction of ECM. Evapoporometry data
indicate that the pores of the membranes fabricated in this study are substantially smaller than
the hydrodynamic radii for ECM components such as collagen I (>80 nm at 37 °C)29, 30 or high
molecular weight hyaluronan (103 nm for mW = 2000 kDa)31, indicating that these constituents
are unlikely to diffuse across the membrane, driving ECM to accumulate in the lumina of the
HFMs. Conversely, the small hydrodynamic radii of cell medium constituents such as bovine
serum albumin (3.48 nm)32 suggests that they can diffuse across the membrane wall unimpeded.
While an in-depth study of ECM bioseparation was beyond the scope of this investigation, the
pore diameter distributions of HFMs, being tunable during the spinning process, may allow for
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selective retention of desirable ECM constituents such as high molecular weight hyaluronan
(anti-inflammatory) while permeating others (e.g., pro-inflammatory low mW hyaluronan)33
Incorporation of ECM components into a fiber geometry is not entirely without precedent.
Alberti and Xu used sheets of decellularized tendon to form fiber-like collagen constructs34;
another notable advance was made by Onoe et al, wherein hydrogels treated with individual
ECM proteins were seeded with various cell lines to generate long fibers with encapsulated
cells35; however, the scaffolding material, being composed of a hydrogel treated with individual
ECM proteins, does not approximate the multimolecular nature of ECM. Past investigations
have demonstrated that subtle aspects of ECM composition play an important role in tissue
regeneration. For example, heparan sulfate proteoglycans (HSPGs) are known to be necessary
for FGF-2 signaling which regulates angiogenesis and the proliferation of satellite cells during
myogenesis36. Further, the combination of glycosaminoglycans and structural proteins in
biomaterials have been shown to improve primary muscle cell proliferation, myoblast fusion,
and skin regeneration, as well as bone formation in vivo37–40. The literature at large therefore
suggests that the inclusion of an array of key ECM constituents in scaffolds bears clinical
relevance for the regeneration of a range of tissues.
Our data suggest that the ECM fibers isolated in this study are bio-complex;
immunoreaction of ECM fibers with antibodies for key ECM constituents, second-harmonic
generation microscopy, and tandem mass spectrometry appear to demonstrate the
multimolecular nature of this material. Several of the ECM constituents identified in ECM
fibers are critical elements for the regeneration of a broad range of tissues including skeletal
muscle, a target of interest for our group41. The fibril- forming collagens I and III found in ECM
fibers are the predominant collagens in skin tendon, bone, and skeletal muscle, and collagen VI
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is an important component of the basement membrane surrounding skeletal muscle42. Biglycan
and decorin, implicated in cutaneous wound healing and key regulators of collagen organization
in skeletal muscle-were also identified43, 44. Further, some notable secreted factors were present
in ECM fibers, including HDGF, IGF-II, and PEDF, playing various roles in liver, bone, and
peripheral nerve regeneration45–48. While detergent-based decellularization techniques tend to
remove various elements of ECM scaffolds, an array of alternative methods exist which may
better preserve glycosaminoglycan and growth factor content49.
Delivery of therapeutic cells for wound-healing, especially progenitor cells, shows unique
promise, as their inclusion into implants can promote angiogenesis50 and diminish the foreign
body response to a biomaterial through the downregulation of pro-inflammatory cytokine
expression51. This, however, presents challenges to scaffold design; the scaffold must obviously
exhibit minimum cytotoxicity, but also have properties that serve to retain the desired
phenotype of the carried cells, as the absence of cues provided in cell culture may cause them to
lose desired characteristics in vivo. It has been observed that cells cultured on substrates coated
with tissue-specific ECM better retain their differentiated phenotypes, and that progenitor cells
exhibit improved proliferation and retention of differentiation potential on these materials52, 53.
This suggests that scaffolds composed of whole ECM may find applicability as carriers of
therapeutic cells. Although cytocompatibility was not examined with progenitor cells, the ECM
fibers produced in this study contain key cell attachment proteins and were supportive of
NIH/3T3 cell cultivation, with rapid proliferation leading to confluency in 72 hours and
negligible cell death. When taken as a whole, the ECM fibers appear to have desirable cell
adhesive properties that could be leveraged to deliver a range of attachment dependent cells.
Furthermore, while NMP has known systemic and local toxicity at low concentrations54, 55, the
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in vivo and in vitro biocompatibility testing results indicate that the solvent can be washed from
the ECM samples prior to implantation.
One of the recognized limitations of first generation ECM fibers is their modest yield and
strength when compared to both synthetic polymers and native tissue ECM. To address this
shortcoming, next generation fabrication approaches could draw from the rich repertoire of cell
culture techniques known to influence in vitro ECM production. Among these, media
supplementation with cytokines possessing known ECM stimulatory properties would appear to
be a logical first approach. HFM’s can be designed with pore diameters that allow the transport
of cytokines including, HGF, VEGF, and CTGF into the lumen, while still trapping the larger
structural proteins of interest. In addition to cytokines, the addition of crowding-inducing
compounds such as dextran sulfate or Ficoll in culture medium has previously been exploited to
increase in vitro ECM deposition and organization and may provide a unique synthetic
approach toward enhancement of ECM fiber yield56, 57. Alternatively the cell itself could be
manipulated to modulate ECM production. Recently developed CRISPR/Cas9 gene editing
techniques58, 59 may provide a pathway for the production of “designer” cells with targeted
ECM production capabilities. For example, the removal of collagen type I genes may create a
cell with enhanced collagen type III production. Similar “knock in” gene editing techniques
could be used to selectively increase ECM production60.
In addition to their use in woven implants, ECM fibers could potentially find utility as the
print material in 3-D bio-printing systems61, 62. The most common type of printing method,
fused deposition, utilizes long filaments to build up an object of interest. We could envision a
system in which the synthetic fibers are replaced by ECM fibers, which are then used to print
organs and tissues. Furthermore, similar in concept to the various synthetic polymer chemistries
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available with traditional 3-D printing systems, it may be possible to print using an assortment
of ECM fibers synthesized using vascular, nerve, and cardiac cells. The data presented in this
study demonstrate that ECM fibers are producible across several cell types, including 3T3
fibroblasts, rat skeletal muscle fibroblasts, and astrocytes. While differences in ECM fiber
composition between each of these cell types were not explored, it is known that the in-vitro
production of ECM does vary by cell types. Variations in ECM production between cell types
could be exploited to create a pallet ECM fibers with varying compositions. Using such a
system, it may be possible to bio-print tissues and organs with heterogeneous structures and
compositions (e.g. vascular fibers embedded within dermal fibers). A further benefit of this
platform is that human cells could be leveraged for the production of allogeneic grafts while
autologous implants could be produced by isolating and culturing the patient’s own cells. While
impractical for the rapid treatment of acute injuries, patient specific implants may be applicable
for the treatment of chronic injuries.
E. Conclusions
The results of this study suggest that:
1. Hollow fiber membrane cell culture is applicable toward the production of continuous threads
of ECM.
2. ECM fibers are amenable to handling and can be assembled into multi-fiber meshes.
3. Isolated ECM fibers exhibit a diverse complement of fibrous ECM proteins, proteoglycans,
and matricellular factors.
4. ECM fibers support the in-vitro cultivation of fibroblasts and are well tolerated by the host
following implantation.
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G. Appendix
Figure Legend:
Figure 1: Hollow Fiber Membrane Fabrication
Hollow fiber membranes were fabricated using a custom-built dry-jet wet spinning system (A).
Polymer and solvent solutions were extruded by pressurized N2 through an annulus and needle
internal to a spinneret. Solutions exiting the spinneret (B: arrow) begin to form a nascent hollow
fiber membrane by non-solvent induced phase separation via contact with the water bath.
Following precipitation, membranes were collected on a motorized take-up wheel (C) at a rate
of 2.2 meters per minute, producing 100 meters of membrane in 45 minutes.
Figure 2: Membrane Structure and Pore Size Distribution
Transverse SEM micrographs (A and B) of representative HFF’s show a concentric asymmetric
membrane with interior and exterior skin layers harboring finger-like pores. Evapoporometric
determination of the membranes’ pore diameter distribution (mean = 39.8 nm ± 3.9 SD, n = 3)
revealed a mesoporous distribution of pores with sizes large enough to permit nutrient transport,
but small enough to trap large structural proteins within the HFM lumen.
Figure 3: ECM Fiber Capture, Manipulation, and Yield
Following one or three weeks in culture, cell seeded hollow fiber membranes were (A)
dissolved in NMP and the accumulated ECM was collected (green). Cell derived material
isolated following dissolution (B) was formed into a continuous filament that could be
manipulated into a conceptual weave (C). ECM fibers were collected from all cells types tested.
ECM yield (D) was sensitive to both cell type and culture duration. Levels not connected by
same letter are significantly different (p<0.05, ANOVA with post hoc Tukey’s test).
Figure 4: ECM Fiber Structure
Representative H&E stained images of transverse (A) and longitudinal (B) ECM fiber thin
sections (thickness = 7 µm) reveals the porous yet interconnect network of accumulated ECM.
SEM micrographs (C and D) of ECM fibers (50x and 1000x, respectively) illustrate the fibers
irregular surface with fibrillar features that are suggestive of ECM.
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Figure 5: ATR-FTIR Analysis
ATR-FTIR spectra for (a) NIH/3T3-derived ECM fibers, (b) polysulfone HFMs cultured with
NIH/3T3 cells for 3 weeks, and (c) uncultured naïve polysulfone HFM were captured using a
Spectrum BX FTIR spectrometer with an ATR accessory and a scanning resolution of 8 cm-1.
Isolated ECM fibers exhibit strong absorbance in the protein-indicative amide bands, with
negligible absorbance for the bands characteristic of polysulfone.
Figure 6: Membrane and ECM Fiber Tensile Properties
Representative HFM stress-strain curve (A), elastic modulus (B) and ultimate strength (C)
values for mechanical tested (tensile) HFM samples (mean + SD, n = 3), with representative
stress-strain curve (D), elastic modulus (E) and ultimate strength (F) for mechanically tested
ECM fibers (mean + SD, n = 3). ECM fiber stress-strain curves were characterized by a toe in
region followed by a near linear rise in stress until failure.
Figure 7: ECM Fiber Immunofluorescence and Decellularization
ECM fibers samples were immuno-stained to detect the presence of fibronectin (A), a key cell
adhesive protein. Imaging via second--harmonic generation was utilized to detect the presence
of fibrillar collagens, key structural proteins. ECM fibers were strongly reactive to both.
Nucleus and actin staining of control (C and E) and decellularized ECM fibers (D and F) was
used to examine process effectiveness. The SDS based decellularization process appeared to
effectively remove cellular debris from ECM fibers without disrupting the continuity of the
fibers.
Figure 8: Biocompatibility
Calcein AM cell viability staining of NIH/3T3 fibroblasts seeded and cultured on an isolated
ECM fiber for 72 hours. Viable cells were attached to and densely distributed across the surface
of the ECM fibers. Stained (H&E) thin sections collected from ECM implanted in Sprague
Dawley rats at 2 (B) and 6 weeks (C). Increased cellularity observed within the dorsal
subcutaneous implantation site at 2 weeks (*) is largely resolved by 6 weeks (n = 3/timepoint).
Scale bar 100 µm unless noted.

78

Figures

Figure 1

79

Figure 2

80

Figure 3

81

Figure 4

82

Figure 5

83

Figure 6

84

Figure 7

85

Figure 8
86

Chapter 3
Production of Extracellular Matrix Fibers via Sacrificial
Hollow Fiber Membrane Cell Culture

Submitted as an original article by:

Kevin Roberts1, John Kim2, Shelby White, Jamie Hestekin3, and Jeffrey C. Wolchok2

1

Cell and Molecular Biology Program, University of Arkansas

2

Department of Biomedical Engineering, University of Arkansas

3

Ralph E Martin Department of Chemical Engineering, University of Arkansas

Corresponding Author:
Jeff Wolchok
125 Engineering Hall
Department of Biomedical Engineering
University of Arkansas
Fayetteville, AR 72701
jwolchok@uark.edu

87

Abstract
Engineered scaffolds derived from extracellular matrix (ECM) have driven significant interest in
medicine for their potential in expediting wound closure and healing. Extraction of extracellular
matrix from fibrogenic cell cultures in vitro has potential for generation of ECM from human- and
potentially patient-specific cell lines, minimizing the presence of xenogeneic epitopes which has
hindered the clinical success of some existing ECM products. A significant challenge in in vitro
production of ECM suitable for implantation is that ECM production by cell culture is typically of
relatively low yield. In this work, protocols are described for the production of ECM by cells
cultured within sacrificial hollow fiber membrane scaffolds. Hollow fiber membranes are cultured
with fibroblast cell lines in a conventional cell medium and dissolved after cell culture to yield
continuous threads of ECM. The resulting ECM fibers produced by this method can be
decellularized and lyophilized, rendering it suitable for storage and implantation.
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A. Introduction
Implantable surgical scaffolds are a fixture of wound repair, with over one million synthetic
polymer meshes implanted worldwide each year for abdominal wall repair alone1. However,
following implantation the synthetic materials polymers traditionally used in the fabrication of
these scaffolds tend to provoke a foreign body response, resulting in inflammation deleterious to
the function of the implant and scarring of tissue2. Further, as the predominant synthetic mesh
materials (i.e., polypropylene) are not appreciably remodeled by the body, they are generally
applicable to tissues where scarring can be tolerated, limiting their clinical usefulness toward the
treatment of tissues with higher-order function such as muscle. While there are many surgical mesh
products which have been applied with clinical success, recent manufacturer recalls of synthetic
surgical meshes and complications from interspecies tissue implants highlight the importance of
maximizing implant biocompatibility, prompting the FDA to tighten regulations on surgical mesh
manufacturers3,4. Implantation of scaffolds derived from patients’ own tissues reduces this immune
response, but can result in significant donor-site morbidity5. Extracellular matrix (ECM) scaffolds
produced in vitro are a possible alternative, as decellularized ECM scaffolds exhibit excellent
biocompatibility, particularly in the case of autologous ECM implants6.
Because of the limited availability of patient tissue to harvest for autologous implantation
and the risk of impeding function at the donor site, the ability to produce ECM scaffolds in vitro
from the culture of human cell lines or, if possible, a patient’s own cells is an attractive alternative.
The primary challenges in the manufacture of substantial amounts of ECM in vitro is the
sequestration of these difficult-to-capture molecules. In previous work, we have demonstrated that
ECM can be produced by culturing ECM-secreting fibroblasts in sacrificial polymeric foams that
are dissolved after the culture period to yield ECM which can be decellularized for
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implantation7,8,9,10. As ECM produced in foams tend to adopt the internal architecture of the foams,
hollow fiber membranes (HFMs) were explored as a sacrificial scaffold for production of threads
of ECM. Described herein are methods tasked for lab scale manufacturing of cell culture quality
hollow fiber membranes and the extraction of bulk extracellular matrix fibers from the same
following a period of fibroblast culture. This static culture approach is readily adoptable by
laboratories containing standard mammalian cell culture equipment. ECM produced by this
approach could be applied toward a variety of clinical applications.
B. Protocol
1. Production of Extracellular Matrix Using Sacrificial Hollow Fiber Membranes
CAUTION: N-methyl-2-pyrrolidone is an irritating solvent and reproductive toxicant. Exposure
to NMP may cause irritation to the skin, eyes, nose, and throat. Solvent-resistant personal
protective equipment should be used when handling NMP. Use of NMP should be performed
within a fume hood.
1.1. Preparation of polysulfone polymer solution for hollow fiber membranes
1.1.1. Weigh 70 g of polysulfone pellets (molecular weight of 35 kD) in a weigh boat using an
analytical balance.
1.1.2. Transfer 314 mL (323.3 g) of N-methyl-2-pyrrolidone (NMP) to a clean borosilicate flask.

1.1.3. Place a stir bar in the flask with NMP and place flask onto stirrer. Set the stirrer to a
moderate rate of rotation.
1.1.4. Use a dry funnel to slowly insert the prepared 70 g of polysulfone into the flask with NMP.
1.1.5. Allow the polymer “dope” solution to stir for three days at room temperature, or until
homogenized.
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1.2. Setting concentricity and cleaning of the hollow fiber membrane spinneret
Note: Spinnerets are commercially available; correct spinneret dimensions are critical to
successful membrane fabrication and are listed in the Table of Materials. Handle the spinneret
very gently, as the spinneret needle is particularly fragile.
1.2.1. Use a screwdriver or drill with an appropriate screwdriver bit to carefully disassemble the
spinneret.
1.2.2. Gently flow acetone through the inlet and outlet of the spinneret, collecting any acetone
and residual polymer in a glass beaker for disposal.
1.2.3. Secure the upper body of the spinneret with the needle facing upward in a table vise.
1.2.4. Place the outlet (bottom) body of the spinneret onto the upper body.
1.2.5. Move the outlet body of the spinneret laterally while holding the upper body fixed on the
vise until the spinneret needle is directly in the center of the outlet body.
1.2.6. Carefully and slowly reinsert the screws connecting the two bodies of the spinneret while
ensuring that the needle visible at the spinneret outlet remains centered.
1.3. Fabrication of polysulfone hollow fiber membranes
1.3.1. Prepare a “bore solution” containing 45 mL of N-methyl-2-pyrrolidone and 255 mL of
deionized water, forming a 15% mixture of NMP with deionized water.
1.3.2. Mount a concentric hollow fiber membrane spinneret 8 cm above the surface of a roomtemperature tap water bath.
1.3.3. Connect the polymer inlet of the spinneret and the bore inlet of the spinneret to two
separate steel pressure vessels having an inner volume of at least 350 mL. Both vessels must
have check valves at their outlets.
1.3.4. Connect each of the pressure vessels to the regulators of separate N2 gas cylinders
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1.3.5. Use a funnel to insert the prepared dope solution (~315 mL) into the pressure vessel
connected to the polymer inlet of the spinneret. Ensure that the top of the vessel is tightly sealed.
1.3.6. Use a funnel to insert the prepared bore solution (300 mL) into the pressure vessel
connected to the bore inlet of the spinneret. Ensure that the top of the vessel is tightly sealed.
1.3.7. Open the check valve for the bore vessel first, then the polymer vessel second. If the
spinneret is sufficiently clean, the bore solution will begin to stream out of the spinneret outlet.
1.3.8. Pressurize both vessels to 1 PSI. Visually confirm that both polymer and bore solutions are
exiting the spinneret, with a continuous white filament precipitating as the combined streams
contact the water bath.
1.3.9. Use long forceps to guide the nascent fiber under the rollers in the center of the bath, and
then wind the nascent fiber around a rotating wheel connected to a motor.
1.3.10. Set the take-up wheel and motor to rotate at a rate of approximately two meters per
minute.
1.3.11. Make minor adjustments to the regulators or take-up wheel speed as needed until a
steady-state flow is achieved. The nascent fiber should form a 90° angle with the surface of the
water bath.
1.3.12. Close the N2 cylinder regulators and pressure vessel check valves and disengage the takeup wheel motor after all polymer and bore solution has been extruded from the vessels.
1.3.13. Remove the prepared hollow fiber membranes and place them into a deionized water bath
for three days, exchanging deionized water once per day to remove residual solvent.
1.3.14. Sterilize the hollow fiber membranes by autoclaving them at 121 °C for 30 minutes or by
immersing them for one day in 70% ethanol.
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1.4. Cell seeding of hollow fiber membranes
Note: All cell culture procedures should be performed within a biosafety cabinet.
1.4.1. Treat the hollow fiber membranes with a 20 &#181;g/mL solution of bovine plasma
fibronectin in PBS (pH = 7.4) to promote cell attachment.
1.4.1.1. Weigh 1 mg of powdered bovine plasma fibronectin in a weigh boat and dissolve it in 1
mL of sterile PBS (pH = 7.4) in a sterile 1.5 mL microcentrifuge tube.
1.4.1.2. Incubate the 1 mg/mL bovine plasma fibronectin solution in the incubator for 30
minutes. Add the solution to 49 mL of sterile PBS in a sterile 50 mL conical centrifuge tube.
1.4.1.3. Incubate the fibers in the prepared 50 mL of bovine plasma fibronectin in an incubator at
37 °C with 5% CO2 for 1 hour. Recollect the fibronectin solution for later use and store in a
sterile 50 mL conical centrifuge tube at 4 °C.
1.4.2. Use sterile microscissors to cut the fibers to desired length (&lt;6 cm).
1.4.3. Seed fibroblast cells directly into the lumina of the hollow fiber membranes at a seeding
density of 100,000 cells per fiber using a 21-gauge needle with 1 mL syringe.
Note: A practicable target for preparing the cell-suspension for loading in the syringe is a
suspension density of 100,000 cells for every 30 microliters of medium.
1.4.4. Place six seeded fibers into a 6 cm diameter Petri dish. Allow the seeded fibers to incubate
at 37 °C with 5% CO2 for five minutes.
1.4.5. Remove the seeded fibers from incubation and culture them for up to 3 weeks in
DMEM/F-12 containing final concentrations of 50 &#181;g/mL L-ascorbic acid and 150
&#181;g/mL L-ascorbic acid 2-phosphate (freshly prepared and sterile filtered), 5 ng/mL TGFß;1 (from sterile filtered aliquots stored at -20 °C), and 1% penicillin-streptomycin in a 6 cm
Petri dish within a 5% CO2 incubator at 37 °C. Exchange cell medium every two days.
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1.5. Extraction of extracellular matrix from cultured hollow fiber membranes
1.5.1. Place cultured fibers into individual scintillation vial using forceps.
1.5.2. Place up to 5 mL of NMP into each vial using a glass pipette.
1.5.3. Immerse the hollow fibers in NMP, performing a total of three exchanges of NMP. Slowly
aspirate the old NMP using a 1 mL pipette to prevent tearing of extracted ECM.
Note: When adding fresh NMP, it is helpful to tilt the vial and allow the NMP run down the
sides, otherwise the remaining ECM scaffold is subjected to shear which may cause tearing.
1.5.4. Remove NMP and rinsed the resulting ECM thread 3 times in deionized water.
1.5.5. Cut a 1/32-inch thick sheet of silicone rubber to a length of 3 inches, width of 1 inch and
cut an 8 mm by 4 mm rectangular mold in the center of the length of rubber.
1.5.6. Place the prepared piece of rubber onto a standard 3-inch by 1-inch microscopy slide and
autoclave at 121 °C for 30 minutes.
1.5.7. Lay each ECM fiber side by side in the 8 mm by 4 mm silicone mold until there is no
visible open space.
1.5.8. Place the mold into a 50 mL conical centrifuge tube and freeze at -80°C until completely
frozen.
1.5.9. Lyophilize frozen ECM mesh overnight or until completely dry. Store the mesh at 4°C
until ready for decellularization.
2. Decellularization of Extracellular Matrix
2.1. Prepare a solution of 1% (w/w%) sodium dodecyl sulfate (SDS) in deionized water.
2.2. Incubate extracted extracellular matrix in the mold in 1% SDS for 24 hours at room
temperature on a rocker with gentle agitation.
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2.3. Rinse extracted extracellular matrix three times in sterile phosphate-buffered saline (PBS)
with gentle agitation, using 3 mL of PBS per rinse.
Note: Rinses should be performed gently to minimize tearing of prepared scaffolds.
2.4. Prepare 1 L of DNAse/RNAse digestion buffer.
Note: DNAse/RNAse digestion buffer may be stored for several months at 4°C.
2.4.1. Weigh 1.54 g of Tris HCl, 308 mg of MgCl2, and 56 mg of CaCl2 in separate weigh boats.
2.4.2. Combine Tris HCl, MgCl2, and CaCl2 with 1 L of deionized water in a large flask with a
stir bar and stir until all components are dissolved.
2.4.3. Sterile filter the digestion buffer with a 0.22 &#181;m filter into a sterile 1 L borosilicate
bottle and store at 4°C.
2.5. Prepare 5 mL of DNAse/RNAse digestion solution.
Note: Digestion solution should be used within 24 hours of preparation.
2.5.1. Weigh 0.125 mg (50 kU) of DNAse I in a weigh boat and add to 5 mL of digestion buffer.
2.5.2. Add 75 &#181;L of RNAse A stock solution to the digestion buffer.
2.6. Add 32 &#181;L of the digestion solution to each prepared mold and incubate at 4°C for 6
hours.
2.7. Aspirate the digestion solution and rinse three times in sterile PBS.
2.8. Aspirate the PBS and incubate scaffolds overnight in 10% penicillin-streptomycin in PBS at
4°C.
2.9. Aspirate the penicillin-streptomycin and rinse scaffolds three times in sterile PBS.
2.10. Place the mold into a 50 mL conical centrifuge tube and freeze at -80°C.
2.11. Lyophilize the decellularized ECM mesh overnight or until completely dry.

95

2.12. Transfer the lyophilized scaffolds within a biosafety hood to a sterile container at 4°C
pending use.
C. Results
Successful production of extracellular matrix from sacrificial scaffolds is contingent on
appropriate scaffold fabrication, cell culture, and solvent rinse procedures. Fabrication of the
hollow fiber membranes is performed using a dry-jet wet-spinning system assembled from
commercially available components (Figure 1) which uses extrusion of polymer solution
through the annulus of a commercially available steel spinneret (inner diameter = 0.8 mm, outer
diameter = 1.6 mm) to generate a nascent tube of polymer solution which precipitates into a
hollow fiber membrane upon contact with a water bath.
An example process for ECM extraction from HFMs is illustrated in Figure 2. Figure
3A shows a transverse cross-section of polysulfone HFMs fabricated under this protocol,
exhibiting outer and inner layers of finger-like pores characteristic of an asymmetric membrane.
In this protocol, cells are seeded specifically in the inner lumen of the membrane and cultured in
6 cm diameter Petri dishes (Figure 3B), with cells tending to proliferate on all surfaces of the
membrane. Cultured membranes can then be subjected to batch NMP and deionized water
rinsing in standard glass scintillation vials (Figure 3C), producing translucent threads of ECM
(Figure 3D). ECM-producing cells remain viable inside HFMs throughout the 3-week period of
culture (Figure 4).
HFMs cultured for three weeks with primary rat skeletal muscle fibroblasts (RSMF) were
dissolved via three exchanges of N-methyl-2-pyrrolidone, after which they were rinsed three
times in deionized water. The extracted matrix, normally being translucent in appearance when
hydrated (Figure 5A), will tend to cloud upon hydration if not subjected to appropriate solvent
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rinsing due to the presence of residual polymer. It should also be noted that the ECM remaining
after dissolution of the membrane is somewhat fragile, requiring care in handling with fine
forceps. ECM fibers assembled into meshes and then lyophilized exhibit an off-white color and
fibrous appearance with a gross longitudinal alignment (Figure 5B).
D. Discussion
The processes described enable the production of bulk ECM biomaterials in vitro using
hollow fiber membranes cast by a dry-jet wet spinning system allowing for inexpensive bulk
production of membranes as well as standard cell culture equipment. While the membranes
fabricated in this protocol are intended for use in cell culture, the system described can also be
adapted for the production of membranes for separation purposes, with pore size distribution and
hollow fiber dimensions tunable by varying spinneret dimensions, polymer used, dope and bore
flow rate, take-up speed, and environmental conditions.13 Though the protocol detailed employs
hollow fiber membranes, in principle any dissolvable cell culture scaffold with appropriate
transport properties such as open cell foams could be used, as demonstrated in previous work7-9.
This general approach appears useful for the production of ECM scaffolds by sacrificial
scaffolds which can more faithfully mimic the internal architecture of tissues. Implants produced
by this protocol in particular exhibit a gross alignment (Figure 5B), which may be of particular
benefit toward the reconstruction of highly aligned tissues such as tendons, ligaments and
skeletal muscle.
Regular exchange of medium and, in particular, supplementation of medium with
ascorbic acid and TGF- ß; is crucial to production of ECM, as ascorbic acid is an essential
enzyme in collagen biosynthesis, and TGF- ß; induces the synthesis of several ECM proteins10.
Additionally, thorough rinsing of ECM with NMP must be performed, otherwise residual
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polymer will remain in the extracted ECM, appearing as a white film during water rinses. Care
must be taken to not overly agitate ECM during membrane dissolution, as it is relatively fragile.
Collected ECM scaffolds intended for implantation must be subjected to a decellularization step
as described to remove xenogeneic epitopes to minimize a potential host foreign body response.
The significance of this technique lies in its production of a biocomplex scaffold of whole
extracellular matrix which can be remodeled by the body’s own wound-healing processes. By
using this approach to produce ECM from cells specific to a target species, it may be possible to
minimize the foreign body response which hinders the clinical effectiveness of this class of
biomaterials; by using cells specific to an individual, the foreign body response may be lessened
further. This approach also allows for the production of ECM targeted toward particular tissues,
with recent reports suggesting that tissue-specific ECM may be particularly effective in certain
applications12. As this protocol allows for production of ECM across various cell lines, implants
combining ECM from several cell types (e.g. muscle, nervous, endothelial) could be used to
tailor implants to more faithfully approximate the structure and chemical complexity of target
tissues. While the ECM meshes presented here were originally intended as scaffolds for wound
repair, they may also have use as platforms for investigations into cell-ECM interactions,
durotaxis, and biosensing. In particular, this approach lends the investigator the ability to
produce ECM from specific cell types of interest which may allow for new insights into the
biological significance of tissue-specific ECM structure, composition and function.
Potential improvements to the ECM production techniques presented here could include
scale-up via the use of dynamic and pre-conditioning bioreactors as well as exploration of
alternative sacrificial scaffold materials and architectures. In particular, transition to a solventless
scaffold removal process would improve the safety of the extraction process; sacrificial scaffolds
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composed of materials which are degradable by enzymes, such as regenerated cellulose, may
allow for solventless ECM extraction14. While the tensile strength of these materials is below
those of synthetic materials, there exist several avenues for improvement of these scaffolds,
including exploration of various culture conditions, media formulations, and sacrificial scaffold
geometries. Recent genetic engineering advances could be leveraged to produce pro-fibrotic cell
lines, which in combination with platforms for ECM capture could enable the production of
scaffolds satisfying clinical demands. Further, existing dynamic culture systems such as
continuous flow-loop hollow fiber membrane bioreactors facilitate high rates of nutrient
exchange conducive to greater and more rapid ECM production, and may be of particular interest
in leveraging this technique for production of larger quantities of ECM for biological research
and clinical use.
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Table 1: Table of Specific Materials
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Material

Supplier

Catalog Number

Comments

1/32 inch thick silicone
rubber
20 mL Scintillation Vials

Grainger

B01LXJULOM

VWR

66022-004

3 inch by 1 inch microscopy
slides
4 °C refrigerator

VWR

75799-268

Thermo Fisher

FRGG2304D

Any commercial 4C refrigerator will suffice.

50 mL conical tubes
6-well cell culture plates
Acetone

VWR
VWR
VWR

21008-178
10062-892
E646

Alternative brands may be used
Alternative brands may be used

Bore vessel

McMaster-Carr

89785K867

6 ft 316 steel tubing

Bovine Plasma Fibronectin
CaCl2

Thermo Fisher
VWR/Amresco

33010018
97062-590

Comes as 1 mg of lyophilized protein

With attached white urea cap and cork foil liner

Cell Culture Incubator w/
CO2
Disposable Serological Pipets

VWR

14673-208

Any appropriate CO2-supplied mammalian cell
incubator will suffice.
Alternative brands may be used

DMEM/F-12, HEPES

Thermo Fisher

11330032

Warm in water bath at 37°C for 30 minutes prior to use

DNase I

Sigma-Aldrich

DN25-10MG

Dope vessel

McMaster-Carr

89785K867

6 ft 316 steel tubing

Ethanol

VWR

BDH1160

Dilute to 70% for sterilization

Fetal Bovine Serum,
qualified, US origin - Gibco
Four 1/4-inch to 1" reducing
unions

Thermo Fisher

26140079

Swagelok

SS-1610-6-4

Mix with growth media at 10% concentration (50mL in
500mL media)
One reducing union for each inlet and outlet of each
vessel

Table 1: Table of Specific Materials
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Material

Supplier

Freeze-dryer/lyophilizer

Labconco

Hexagonal Antistatic
Polystyrene Weighing Dishes
Hollow fiber membrane
immersion bath
Hollow Fiber Membrane
Spinneret

VWR

Hot plate/stirrer
Human TGF-β1
L-Ascorbic acid

VWR
PeproTech
Sigma-Aldrich

http://www.aeispinnerets.com/sp
ecifications.html
97042-634
100-21
A4544-25G

L-Ascorbic acid 2-phosphate

Sigma-Aldrich

A8960-5G

L-glutamine (200 mM) Gibco
MgCl2

Thermo Fisher

25030081

VWR/Alfa Aesar

AA12315-A1

Minus 80 Freezer
N2 gas cylinders (two)
NIH/3T3 cells

Thermo Fisher

UXF40086A

Any commercial -80C freezer will suffice.

ATCC

CRL-1658

Alternative fibrogenic cell lines may be used.

N-methyl-2-pyrrolidone

VWR

BDH1141

Alternative brands may be used

AEI

Catalog Number

Comments

117 (A65312906)
89106-752

Any lyophilizer will suffice.
Any weigh boat will suffice

34L polypropylene tubs may be used or large bath
containers can be fabricated from welded steel sheets
Made to order. Inner diameter = 0.8 mm, outer diameter
= 1.6 mm

Mix with growth media at 1% concentration (5mL in
500mL media)

Table 1: Table of Specific Materials
Material

Supplier

Catalog Number

Comments

Penicillin/Streptomycin
Solution

Thermo Fisher

15140122

Mix with growth media at 0.1% concentration (0.5 mL
in 500mL media)

Polysulfone

Sigma-Aldrich

428302

Portable Pipet-Aid Pipetting
Device - Drummond

VWR

53498-103

Any polysulfone with an average Mw of 35,000 daltons
may be used
Alternative brands may be used

PTFE tubing (1/4-inch inner
diameter)

McMaster-Carr

52315K24

Alternative brands may be used.
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Independently isolated from rat skeletal muscle.
Alternative fibrogenic cell lines may be used.

Rat skeletal muscle
fibroblasts
RNase A

Sigma-Aldrich

R4642

Silicone sheet
Take-up motor
Tris HCl

McMaster-Carr
Greartisan
VWR/Amresco

1460N28
B071GTTSV3
97063-756

Two needle valves

Swagelok

SS-1RS4

200 RPM DC Motor
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G. Appendix
Figure Legend:
Figure 1: Illustrated process flow for casting hollow fiber membranes
Hollow fiber membranes are manufactured using the ubiquitous non-solvent induced phase
separation method (NIPS) using a system prepared from commercially available components listed
in the table of specific materials. Polysulfone in NMP (17.8 w/w%) and NMP bore solutions (15
w/w% NMP in water) are extruded from separate stainless steel vessels by pressurized N2 into a
spinneret, generating a nascent hollow fiber membrane at the spinneret outlet which fully
precipitates upon contact with the tap water precipitation bath. Nascent hollow fiber is manually
guided under and over guides and allowed to collect on a rotating motorized take-up wheel at a
rate of 2.3 meters per minute.

Figure 2: Illustrated production of ECM from cultured hollow fiber membranes
Hollow fiber membranes are seeded with fibroblasts and cultured for three weeks, followed by
exchange of NMP 3x and exchange of deionized water 3x.

Figure 3: Culture and extraction of ECM
Asymmetric mesoporous hollow fiber membranes (A) were cultured for three weeks with RSMF
cells in DMEM/F-12 with supplemented ascorbic acid and TGF-ß; (B). Cultured hollow fibers (C,
D top) were dissolved via 3 exchanges in n-methyl-2-pyrrolidone then rinsed three times in
deionized water, resulting in continuous threads of ECM (D, bottom). High magnification scanning
electron microscopy micrograph of the ECM fiber surface (E).

Figure 4: Cell viability on hollow fiber membranes
Representative hollow fiber membranes cultured with RSMF cells for three weeks were
longitudinally sectioned using a fine razor to reveal the luminal surface of the HFMs and subjected
to live-dead staining with Calcein AM and EthD-1. Viability staining revealed a confluent layer
of viable cells with negligible EthD-1 fluorescence.
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Figure 5: Assembly of ECM implant
Individual extracellular matrix threads (n = 30) derived from culture of RSMF cells were placed
lengthwise into a silicone mold (A) and decellularized by 1% SDS followed by treatment with
DNAse I, RNAse A, and penicillin-streptomycin. Decellularized ECM was then lyophilized,
yielding an off-white mesh with a fibrous appearance and longitudinal architecture (B).
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Abstract
Evapoporometry is a promising emerging method of pore diameter characterization with particular
applicability toward characterization of mesoporous materials. The evapoporometric approach is
notable for requiring relatively inexpensive and ubiquitous laboratory equipment relative to other
pore characterization methods; however, to date the method has largely been relegated to groups
dedicated to membrane characterization due to the nontrivial data analysis involved. In an effort
to extend the use of this promising method beyond membrane specialists, we demonstrate a free
open-source software aid for standardizing evapoporometry data analysis and assess its
applicability for pore size of macroreticular ion exchange resins as well as estimation of surface
area, a key property of interdisciplinary interest.
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Introduction
The performance of porous materials used in separations processes is dictated primarily by
their pore size distributions, making accurate characterization of pore size a critical aspect of the
manufacturing process.1 In particular, mesoporous materials have broad application in industry as
ultrafiltration membranes, catalysts, adsorbents, and drug carriers, where consistent performance
requires tight control of pore size distribution, porosity, and surface area.2,3 A variety of techniques
exist to characterize pore diameter, by direct methods –such as electron microscopy- or indirect
such as mercury porosimetry.4 However, image analysis of pore size is performed on very small
portions of the sample which may not be truly representative of the whole, while methods based
on liquid displacement or gas adsorption often require rather expensive equipment and significant
technical expertise on the part of the investigator. Further, methods such as mercury porosimetry
require application of high pressures for detection of small pores which can affect the structure of
the sample during measurement.5
Evapoporometry (EP) is a relatively new method for indirect determination of pore
diameter distribution based on the Kelvin equation, which relates vapor pressure to the curvature
of liquid-gas interfaces within liquid-filled pores.6 Unlike gas adsorption/desorption or
permporometry which characterize capillary condensation within pores7, evapoporometry relies
on the measurement of the isothermal evaporation of a fluid from filled pores of a sample contained
within a cylindrical test cell, with evacuation of liquid from larger pores preceding that of smaller
pores due to increasing vapor pressure depression as pore size decreases. Krantz et al developed a
mass transfer model demonstrating that the Kelvin equation can be rearranged to calculate pore
diameter directly from the evaporation rate of fluid from pores6,8,9 via:
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Equation 1
𝑑= −

4𝑦𝑉
𝑊
𝑅𝑇𝑙𝑛 𝐴0
°
𝑊𝐴0
Where y is the surface tension of the liquid within the pores, V is the vapor molar volume,

R is the universal gas constant, T is absolute temperature, 𝑊𝐴0 is the evaporation rate of liquid
°
from pores, and 𝑊𝐴0
is the evaporation rate of the fluid layer initially present above the sample.

Fisher and Israelachvili found the Kelvin equation to be valid for menisci with a mean radius of
curvature > 4 nm10, a finding later validated by Mitropoulos11. While the evaporating liquid most
used in evapoporometry studies has been 2-propanol, the use of fluids with a higher surface tension
and liquid molar volume have been found to allow for characterization of pore diameters up to 365
nm.9 Unique to evapoporometry is the capability to evaluate the pore size distribution of samples
across a range of fluids without the application of pressure, enabling the investigator to predict the
separation properties of the sample in different liquid media.
Despite the promising agreement of evapoporometry-measured pore diameter distributions
with competing methods, evapoporometry has thus far largely been applied to ideal wellcharacterized samples such as commercial asymmetric Anopore membranes6,9, having regular pore
and support structures allowing for a correction of evaporative mass-loss data necessary for highly
asymmetric membranes.12,13 In contrast, the irregular substructure14 of solvent-cast asymmetric
membranes precludes this asymmetry correction, making the method most appropriate as a tool
for detecting relative changes in pore diameter distribution, as in the case of fouled asymmetric
membranes.15
In this work, we present an open-source standalone Python application for data analysis
(Evapore), and assess the capability of software-aided evapoporometry for characterizing the pore
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size distributions of asymmetric anodisc membranes macroreticular ion exchange resins,
ubiquitous in water softening, purification, and catalysis.16,17. It is anticipated that the availability
of a software platform for EP analysis will encourage the adoption of this useful adjunct to goldstandard pore measuring techniques, and that its application toward nonclassical porous materials
may yield fruitful insights for studies outside of the field of membrane research.
Methods
Evapoporometry
An EP apparatus comprising a custom-fabricated PTFE test cell, analytical balance, and
laptop interfaced to the balance by RS232-USB was assembled as described previously (Figure
1).8 Samples were immersed in an evaporating fluid for 2 hours, then sealed into the test cell with
a liberal application of vacuum grease on the periphery of the test cell to ensure one-dimensional
mass transfer, with several drops of fluid added above the sample to produce a free-standing layer.
2-propanol was selected as the evaporating fluid due to its nonwetting properties as well as its use
in previous EP publications. Activated carbon was placed in scintillation vials surrounding the
weighing plate as a desiccant to minimize the retention of volatile fluid in atmosphere. An XS105
balance (Mettler Toledo; Greifensee, Switzerland) with a resolution of 10 µg was used to monitor
evaporative mass loss over time under stable ambient temperature.
Scanning Electron Microscopy
Visualization of sample surface morphology was achieved through direct use of a Nova
Nanolab 200 following sputter-coating with gold-palladium before and after immersion for 2
hours in 99% 2-propanol.
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Data analysis
An open-source standalone program (Evapore) with a graphic user interface was
developed in Python 3.7 to automate evapoporometry data analysis in order to minimize user
error and ensure reproducibility. With source code and executable files available at
github.com/RobertsEng/Evapore, the program proceeds as follows:
1. The user is prompted by a dialog to load a headerless .XLSX file with the first column
containing evaporative mass loss data for a test cell containing a fluid-saturated sample and
an additional small layer of fluid overlying the sample.
2. The user is prompted to input parameters related to the acquisition of gravimetric data for
a layer of volatile fluid evaporating from an otherwise empty test cell, including the fluid
used, absolute temperature, and time interval between acquisition of mass measurements.
3. The mass column is subjected to a moving average (i = 20) to minimize the effect of noise
on the calculated pore diameter distribution.
4. The evaporation rate (g/s) is calculated from the slope of a mass versus time array.
5. An interactive plot of evaporation rate versus time is rendered to the user, prompting them
to select the initial x-axis values at which the period of constant evaporation occurs (WA0),
corresponding to evaporation of the layer of fluid overlying the sample. The evaporation
rates are converted to mol/s via division by the molecular weight of the fluid used. An
average evaporation rate (WA0) and standard deviation for this period are then calculated.
6. WA0 is used to determine the start point at which evaporation of fluid from the pores of the
sample begins, corresponding to the first point on the graph at which W A < WA - 3σ. A
horizontal line with height equal to this evaporation value is overlaid on the graph to guide
the user.
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7. The pore diameter corresponding to each instantaneous evaporation rate is computed using
equation 2.
8. Instantaneously measured pore diameters are grouped into bins with a width of 5 nm. The
percentage of pore-evaporated mass for each bin is used to determine an average pore size
by the Bachmann-Anderson-Gurvitsch rule. The user is prompted to save pore diameter
data in .CSV format and an interactive graph of pore size distribution is rendered.
Surface area of samples was assessed using the Bachmann-Anderson-Gurvitsch rule relating
total pore volume to surface area, generally applied to materials with cylindrical, rigid, and welldefined pores18-22:
Equation 2
D = 4V/S
Where D is mean pore diameter, V is specific pore volume (m3/g), and S is specific surface
area in m2/g. Mean EP pore diameter is substituted for D and the liquid volume of fluid evaporated
during the pore draining period is substituted for V, allowing for calculation of specific surface
area. Here, a specific volume derived from the density of the EP fluid used and mass lost during
pore draining are substituted for V as an analog for specific pore volume.
N2 Adsorption-Desorption
Comparison of evapoporometry surface area measurements for Amberlyst-15 ion
exchange resin was enabled by analysis of the resin in an Autosorb iQ automated gas sorption
analyzer and data processing in ASiqwin software (Quantachrome). Samples were degassed at 100
°C for 21 hours prior to measurement.
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Statistical methods
All statistical analysis was performed in Graphpad Prism v8.0.1 (Graphpad Software, San
Diego). ANOVA with post-hoc Tukey’s test was used for all significance testing between groups
(α = 0.05). Quantitative data are presented as mean ± standard deviation.
Results
Scanning electron microscopy of anodisc membranes revealed highly ordered and dense
pore structures for Anodisc membranes consistent with literature (Figure 3A) with an irregular
and scattered pore structure for Amberlyst 15 ion exchange resin beads. Imaging of membranes
and ion exchange resin following a 2-hour immersion in 2-propanol resulted in no evident
changes to surface morphology.
Evapoporometric analysis of pore diameter for Anodisc 13, Amberlyst 15, and Anodisc
47 samples yielded mean pore diameters of 24.9 ± 2.7 nm, 30.1 ± 3.0 nm, and 108 ± 1.1 nm,
respectively (Figure 4A). Linear regression analysis of evapoporometric pore determination
against nominal manufacturer-reported mean N2 adsorption-assessed pore diameter revealed a
strong agreement (R2 = 99.37) and significantly non-zero slope (p < 0.0001) (Figure 4B).
Representative pore diameter distributions for ANO-13, AMB-15, and ANO-47 ranged from the
5-35 nm, 10-85 nm, and 5-300 nm bins, respectively. One-way ANOVA indicated significant
differences within the diameter dataset (p <0.0001), with a post-hoc Tukey’s test indicating
significant differences in diameter across ANO-13 versus ANO-47 (p < 0.0001) and AMB-15
versus ANO-47 (p<0.0001).
Estimation of surface area by application of the Bachmann-Anderson-Gurvitsch rule for
Anodisc 13, Amberlyst 15, and Anodisc 47 samples indicated approximate specific surface areas
of 203 ± 37 m2/g, 123 ± 4.62 m2/g, and 2.69 ± 1.42 m2/g, respectively (Figure 5). One-way
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ANOVA indicated significant differences across the dataset (p = 0.0002), with post-hoc Tukey’s
test indicating significant differences across all comparisons (p = 0.0131 for ANO-13 v AMB15, p = 0.0001 for ANO-13 vs ANO-47, and p = 0.0025 for AMB-15 v ANO-47). Measurement
of Amberlyst-15 surface area by Brunauer–Emmett–Teller analysis of N2 adsorption-desorption
indicated a surface area of 42.5 m2/g, identical to widely reported BET analysis of this material23,
suggesting an overestimation of specific surface area by evapoporometry.
Discussion
In this work we have evaluated the accuracy and precision of a standalone software
application in analysis of Evapoporometry data for pore diameter distribution and surface area
characterization for porous materials, including an ion exchange resin with a macroscale
geometry substantially different from synthetic membranes analyzed in previous reports. While
evapoporometry exhibits the advantages of limited equipment expense and straightforward
experimental protocol, the data analysis involves a series of nontrivial data analysis steps
including graphical analysis which leads to variation in final results between individual
investigators. While an element of graphical analysis still exists in Evapore data processing in
terms of the selection of the initial steady-state region of evaporation, the relative standardization
of the process and automation of remaining steps minimizes between-user variation and enables
rapid reanalysis.
While previous reports have investigated evapoporometry as a general method of pore
diameter determination in the context of idealized alumina membranes there is substantial
interdisciplinary interest in the determination of pore diameter distribution for more irregular
materials such as nonsolvent-induced phase separation-cast membranes, macroporous ion
exchange resins, electronspun nanofibrous meshes, as well as soils, where pore size distribution
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can be used to predict properties ranging from gas diffusion to soil productivity24 (with the
advantage that such samples can be analyzed by natural evaporation of water). We demonstrate
that a semi-automated software-based analysis allows for fine determination of pore size for
mesoporous materials, but notably with a lesser variation in comparison to previous reports for
membranes of identical nominal pore size. It is additionally shown that evapoporometry
faithfully reproduces the nominal mean pore diameter for Amberlyst 15, a macroporous ion
exchange resin, with
We further demonstrate that while expected trends in surface area between different
samples are reflected in relative terms in the evapoporometric determination of surface area via
the Gurvitsch-rule, evapoporometry appears to substantially overestimate surface area compared
to BET, indicating at present that the method appears unsuitable for determination of absolute
surface area. Finer exploration of mathematical models applicable to EP may yield insights to
reduce discrepancies between EP and gold-standard methods.
Combination of this software-aided approach with open-source data acquisition
technology is anticipated to reduce the financial, time, and personnel costs of pore size analysis
and reduce the barrier of entry for investigators interested in mesoporous pore size and surface
area properties but for whom existing methods are cost-prohibitive or otherwise inappropriate.
The Evapore software tool developed in this tool is publicly available in both original source and
executable form at https://github.com/RobertsEng/Evapore.
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Appendix
Figure Legend:
Figure 1: Illustrated evapoporometry workflow
Samples were immersed in volatile fluid (2-propanol) for two hours to ensure complete
saturation and pore filling, then secured to the base of a custom-fabricated PTFE test cell (ID =
35 mm). A small amount of volatile fluid (<500 µL) was further added to the bottom of the test
cell overlying the sample to produce a standing layer of fluid. Evaporative mass loss from the
test cell is then monitored at stable ambient temperature (25 °C) using an analytical balance with
a resolution of 10 µg. Raw mass and acquisition time data were input into a standalone python
application to yield mean pore diameter, pore diameter distribution, and estimated surface area.
Figure 2: Standardization of data processing in Python enables rapid and facile
interpretation of evapoporometry mass loss data
A standalone windows-executable Python application with graphic user interface (Evapore) was
developed for evapoporometry data analysis wherein the user is prompted to (a) specify the
evaporating fluid used, the constant temperature at which the mass loss experiment was
conducted, as well as the data acquisition interval from the analytical balance used. The user
loads a headerless .XLSX file containing mass data in the first column, after which Evapore
renders an interactive graph (b) where the user is prompted to select the period of steady-state
evaporation corresponding to evaporation of the fluid layer overlying the sample. Evapore then
displays threshold value of evaporation rate at which pore draining is considered to begin (c, red
line), and the user selects the first data point that is continuous with the remainder of the curve.
Based on the physical properties of the fluid used, temperature, and acquisition interval, Evapore
computes both an average pore diameter and pore diameter distribution which are rendered to the
user, with the user prompted to save final result data in .CSV format, compatible with most
statistical software.

Figure 3: Surface morphology of assessed porous materials
Evapoporometric pore size data were assessed for (a) Anodisc membranes with a nominal mean
pore diameter of 100 nm and (b) Amberlyst 15 ion exchange resin beads with nominal mean pore
diameter of 30 nm.
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Figure 4: Assessment of pore diameter agrees with nominal properties of porous materials
(a) Evapoporometric mean pore diameters assessed by Evapore correlate strongly (B) with
nominal reported N2 adsorption pore diameters (slope significantly different from zero, p <
0.0001), with pore diameter distributions for (c) Anodisc 13 membranes, (d) Amberlyst 15 ion
exchange resin, and (e) Anodisc 47 membranes.

Figure 5: Estimation of material surface area by evapoporometry
Assessment of material surface area by evapoporometry via the Bachmann-Anderson-Gurvitsch
rule demonstrated the expected inverse trend of surface area relative to pore diameter, but
appears to overestimate surface area relative to BET (†, 42.5 m2/g for Amberlyst 15 ion

exchange resin).
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Abstract
Volumetric muscle loss overwhelms skeletal muscle’s ordinarily capable regenerative
machinery, resulting in fibrosis and severe functional deficits which have defied clinical repair
strategies. In this manuscript we pair the early in vivo functional response to treatment of
volumetric muscle loss injury using three separate implant strategies to the global transcriptome
response for each group. We demonstrate that an implant comprising an allogeneic
decellularized skeletal muscle scaffold seeded with autologous minced muscle expedites
functional recovery from volumetric muscle loss concurrent with a remarkable increase in
neuritogenesis and axon guidance transcription in the early period following injury and repair,
with an unexpected absence of coordinated myogenic transcription. Importantly, these responses
are observed only when both scaffolding and cellular components are delivered, with the
combinatorial group recovering 54.7% of the contractile force lost to injury at two weeks postinjury, compared to -11.8% and 11.3% among groups receiving minced muscle or scaffolding
only, respectively. The functional recovery and transcriptome profile observed with this
treatment strategy demonstrate an unexplored yet critical synergy between scaffolding and cells
during muscle regeneration and invites exploration of the underappreciated role of peripheral
neuroregeneration in volumetric muscle loss.
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A. Introduction
Skeletal muscle exhibits an innate ability to regenerate small amounts of functional tissue
following minor traumas including strains and contusions.1 The immediate response to mild
muscle injury consists of partial necrosis of damaged myofibers and their degradation by
neutrophils, followed by migration of macrophages to the injury which continue to degrade
necrotic tissue.2 Hepatocyte growth factor released from injured muscle matrix promotes
satellite cells residing between myofibers to reenter cell cycle, proliferate, and migrate to sites of
injury as myoblasts, after which they undergo fusion to form nascent myofibers.3-5 Over the
course of several days, the community of macrophages present will shift toward a range of
phenotypes secreting signals promoting myoblast differentiation and connective tissue deposition
by fibroblasts.6 Alternatively, in the case of volumetric muscle loss (VML), satellite cell
recruitment and differentiation are overwhelmed by inflammatory signaling and the destruction
of the basal lamina, leaving fibroblasts as the predominant cell population in the wound during
the repair and remodeling phase. Consequently, VML injuries result in the formation of noncontractile scar tissue which prevents the intrusion of nascent myofibers, contributing to a
permanent deficit in muscle force.
There exists no consensus on a standard of care for regenerating lost muscle, due to a
lack of proven therapies and the heterogeneous presentation of VML injuries. Exploratory
biomaterials for treatment of VML generally attempt to inhibit fibrosis and promote myoblast
differentiation; typically composed of decellularized skeletal muscle (DSM) or porcine small
intestinal submucosa, use of these scaffolds in isolation has yielded mixed results.7-11 Particularly
promising in preclinical study are combinatorial therapies in which precursor cells are combined
with tissue scaffolds fitted to the geometry of the wound and directly implanted.12-15 One such
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cell delivery method of interest to our group and others16-22 is the use of minced muscle sourced
from small portions of autologous donor muscle, a clinically translatable source of precursor
cells.23 Cells from minced muscle (MM) autografts contribute directly to fiber regeneration
following VML, yet have achieved only modest functional recovery when used in isolation.24
What is especially intriguing are the functional improvements that can be achieved when a DSM
matrix and MM autograft are used in combination. Founded on the premise that the matrix
provides an enabling substrate for regeneration by codelivered cells while minimizing the
amount of donor tissue required, this implant strategy has recovered half of muscle force lost to
VML in preclinical models25.
The breadth of molecular modes by which these combinatorial therapies may coordinate
force recovery remains unclear, particularly during the early weeks following injury. The lower
level of recovery occurring in the presence of allogeneic matrix or minced muscle alone
emphasizes the importance of a multifactorial approach to VML treatment, and suggests a
biomolecular synergy between these components which to date has not been explored in depth.
Here we profile the transcriptome-wide responses of VML-injured tissue to scaffolding and cell
delivery strategies in isolation and combination to better assess early regulatory changes
potentially mediating differences observed in functional outcome between implant schemes.
Clarifying the effects of these therapies on the complex inflammatory, fibrotic, and regenerative
networks in the early period following injury contributes to a foundational understanding of
VML pathobiology upon which to further refine VML repair strategies for the clinic.
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B. Results
Minced muscle-loaded decellularized muscle improves early VML functional outcome
Ablation of the rat tibialis anterior resulted in defects clearly visible at 3 and 14 days post
injury (DPI) (Figures 1 and 2). While no clear differences were noted in the gross appearance of
VML and MM-treated muscles, DSM and DSM+MM implants remained intact in the site of the
defect, with the DSM+MM appearing better integrated with the muscle than DSM. No
significant differences in animal growth were observed. Masses of excised TA muscles were
statistically indistinguishable from excised contralateral uninjured TA across all groups at 3 DPI,
while the mean mass of VML and MM-treated TA were significantly lower relative to normal at
14 DPI (78.5% of normal mass with p = 0.0181 and 80.6% of normal mass with p = 0.0351,
respectively).
Unrepaired, repaired, and uninjured contralateral limbs were assessed for peak tetanic
force output at both time points. At 3 DPI, MM and DSM+MM -treated groups exhibited
significantly lower force output (N/kg body weight) than uninjured contralateral muscles (64.2%
and 41.6% of uninjured limb force, respectively). Unrepaired, MM, and DSM treatments
exhibited significantly lower force output (N/kg bw) at 14 DPI relative to uninjured muscles
(53.6%, 48.2%, and 58.8% of uninjured limb force, respectively) while muscles treated with
minced muscle loaded onto decellularized muscle matrix (DSM+MM) exhibited a force outcome
not statistically different from uninjured limbs (79% of normal limb force, p = 0.0648) (Figure
2B).
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Muscle transcriptomes vary sharply with repair strategy at two weeks post-injury
Analysis of RNA-seq data in EdgeR revealed a cumulative total of 2686 differentially
expressed genes (DEGs) across all groups relative to controls (Figure 3). A broadly similar
pattern of gene expression was observed across all groups at 3 DPI, with the notable exception of
a marked downregulation of a broad array of macromolecule metabolism genes within the MM
group (Figure 3B-C). The 3 DPI muscle transcriptomes were otherwise largely dominated by
upregulation of genes categorized by gene ontology enrichment analysis as related to cell
migration and regulation of the immune response.
Gene expression within the unrepaired and MM-repaired groups at 14 DPI demonstrated
a broad return to baseline levels. The VML14 group exhibited upregulation of 52 genes, 2 of
which (LIPG and RPLP1) were unique to this group. Of the remaining 50 transcripts, gene
ontology enrichment identified 22 associated with cell differentiation and 6 related to skeletal
muscle tissue development. The MM14 group demonstrated upregulation of only 2 transcripts,
CAV1 and SCD. CAV1 –the only transcript commonly upregulated among all 14 DPI groups- is
a key constituent of caveolae, a subtype of lipid raft involved in transmembrane signaling26,
endocytosis27, mechanoprotection across several cell types28, and sarcolemmal organization.29
SCD encodes the rate-limiting enzyme for the synthesis of monounsaturated fatty acids, is
associated with fat metabolism and deposition of fat in skeletal muscle30, and is notably the only
differentially expressed gene upregulated in all groups regardless of time point.31
While the DSM14 and DSM+MM14 groups demonstrated differential expression of 832
genes largely related to the acute inflammatory response also differentially expressed by all 3
DPI groups, 52 DEGs were shared only by DSM14, with 90 DEGs unique to DSM+MM14
alone. Extracellular matrix organization, cell surface receptor signaling, and axonogenesis gene
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ontology categories comprise 8, 17, and 6 of the 52 DEGs shared by these two groups,
respectively. Regulation of cell communication, anatomical structure morphogenesis, and
membrane protein localization comprised the major gene ontology categories overrepresented
among the 90 DEGs unique to DSM+MM14. The DSM14 and DSM+MM14 groups each
exhibited remarkable upregulation of transcripts with some role in cell movement annotated by
IPA, with 424 and 540 cell movement DEGs, respectively.
Myogenesis and angiogenesis transcription are generally unaffected by VML repair
Assessment of all groups for the classic markers of precursor cell myogenesis indicate a
lack of coordinated myogenesis signaling with the exception of an observation of upregulated
MYF5 and MYOG within the DSM group relative to uninjured controls at 14 DPI (p = 0.004 and
p = 0.0130, respectively). (Figure 4A-B) Assessment for angiogenesis markers indicate
nonexpression across all groups for the angiogenic VEGFa and no consistent differential
expression for associated angiogenic transcripts. (Figure 4C-D) Ingenuity Pathway Analysis
predicted no significant changes to myogenesis or angiogenesis at the pathway level.
Profound upregulation of ECM and phagocytosis transcripts persists in DSM and DSM+MM
repair
Transcripts for many well-described matrix structural constituents and enzymes,
including fibrillary collagens, collagen nucleators, and matrix metalloproteinases, were
consistently found by EdgeR to be profoundly upregulated in both the DSM and DSM+MM
groups at 14 DPI (Figure 5). Ingenuity Pathway Analysis identified significant upregulation
within the hepatic fibrosis canonical pathway for each (p = 1.04E-14 with 39 DEGs and 5.13E18 with 49 DEGs, respectively). IPA also identified a general upregulation of transcripts with
some role in fibrogenesis for the DSM (p = 2.87E-19 with 89 DEGs) and DSM+MM (p = 3.57E-
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27 with 119 DEGs) groups at this timepoint, respectively. Upregulation of the Fcγ receptormediated phagocytosis pathway was further identified (p = 1.62E-13 with 26 DEGs and p =
1.83E-13 with 29 DEGs, respectively, Figure 6). Further, the Cell Movement category of
transcripts was found by Ingenuity Pathway Analysis (IPA) to be significantly upregulated for all
groups at 3 DPI and the DSM (p = 2.06E-80) and DSM+MM (p = 5.26E-101) groups at 14 DPI.
Expression of neuritogenesis and axonogenesis associated genes is upregulated in DSM+MM
repair of VML
Ingenuity Pathway Analysis identified significant upregulation (p = 2.96E-03) of the
Neuritogenesis Diseases and Functions annotation within the DSM+MM group at 14 DPI, with
six genes predicted to be upregulating neuritogenesis. (Figure 7A-B). These include RELN,
S100B, AHRGEF25, DLG4, GEM, and PMP22, all of which are known to be associated with
neurite outgrowth.32-37 The DSM-only group also exhibited significant upregulation of
ARHGEF25, which has also been shown to promote skeletal muscle regeneration in mouse
tibialis anterior,38 while other groups were insignificant for all neuritogenesis related transcripts
at the 14 DPI timepoint. Further, Gene ontology enrichment analysis revealed 6 additional genes
upregulated in both the DSM14 and DSM+MM14 groups related to axonogenesis, including
ROBO2, BRSK1, MT3, RND2, DCX, and DIXDC1 (Figure 7C-D). In particular the binding of
ROBO2 receptor with its ligand Slit2 is necessary for the normal bundling of nascent axons
during muscle innervation.39 When the log2FC threshold for calling differential expression was
lowered to 1.0, IPA identified substantial changes in the Axonal Guidance Signaling canonical
pathway in several groups, with 185, 182, 139, and 121 differentially expressed genes in the 3
DPI VML, MM, DSM, and DSM+MM groups, respectively. In contrast, at 14 DPI changes in
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axonal guidance signaling were observed only in the DSM and DSM+MM groups, with 78 and
116 differentially expressed genes, respectively.
C. Discussion
In this work we have profiled the global transcriptome expression of the tibialis anterior
cell community in response to volumetric muscle loss (VML) and subsequent biomaterials-based
repair strategies. A standard of care for VML remains elusive; implantation of autologous
minced muscle grafts is capable of promoting some degree of repair but requires prohibitively
large amounts of donor tissue for extensive VML wounds. An emerging alternative is the use of
extracellular matrix scaffolds; however, many of those piloted in the literature thus far have
mixed impacts on functional outcome. Intriguingly, the application of autologous minced muscle
(MM) pastes to decellularized muscle matrix (DSM) prior to implantation has been shown to
restore half of the peak contractile force lost to VML (81% of uninjured peak contractile force vs
62%), while other minced muscle or ECM grafts result in only modest improvement to force
outcomes.25 Our observation of significant functional recovery (79% of uninjured limb force) in
groups treated with DSM+MM at 14 days post-injury corroborates this finding and further
suggests that a substantial fraction of force recovery mediated by this combinatorial repair occurs
relatively early in the wound-healing process, a novel finding not seen in previous investigations
potentially due to assessment of recovery at extended time points (8+ weeks post-injury). Our
data suggest that neither the MM or DSM components in isolation are sufficient to facilitate this
expeditious force recovery; it is only when combined that they act synergistically to restore force
in this manner.
Intriguingly, confounding the force recovery seen with DSM+MM repair is the
observation of no coordinated changes in myogenesis nor angiogenesis signaling, suggesting that
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the recovery observed is unlikely to be mediated by myofiber regeneration alone. Chen and
Walters have suggested that muscle-derived ECM mediates force recovery in part through the
provision of a physical bridge through which force can be transmitted across the site of injury.40
Corona et al further show that relative to untreated VML injuries, implantation of muscle ECM
biases collagen deposition toward the defect site rather than intramuscular deposition and
prevents reductions in fiber cross-sectional area, suggesting a protective effect of implanted
muscle ECM against muscle atrophy following injury.41 Our data indicate that the DSM
component causes substantial and persistent upregulation of transcripts for the chief fibrillary
collagens, collagen nucleators42, as well as collagen-degrading matrix metalloproteinases, all
participants in the remodeling of ECM.43 This combined with the profound upregulation of
phagocytosis and cell movement related genes illustrates a complex environment within the
wound in the weeks following VML; while decellularized skeletal muscle has been shown to
promote myogenesis by acting as a substrate for satellite cell migration and differentiation,44 the
absence of myogenic signaling, early onset of force recovery within the DSM+MM group, and
statistically significant force deficit observed for the DSM-only group in this study suggest that
non-myogenic processes are contributing to VML recovery in the case of DSM+MM repair.
Our observation of substantial upregulation of neuritogenesis and axonogenesis related
transcripts suggests a possible neurologic involvement in the efficacy of DSM+MM repair of
VML. Further, when the log2(FC) threshold for calling differential gene expression is lowered
from 1.5 to 1, IPA detected 116 differentially expressed genes in the DSM+MM14 group within
the Axon Guidance Signaling canonical pathway. Further, the significant deficits in terminal
muscle mass, contractile force, and lack of neuroregenerative transcription among unrepaired
and minced muscle repaired groups are consistent with the phenomenon of denervation-induced
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muscle atrophy.45 While most VML investigations in the literature have focused on the influence
of myofiber atrophy, myogenesis, or immune involvement, Corona et al recently demonstrated
that VML results in chronic axotomy of ~69% of motoneurons innervating the tibialis anterior,
concurrent with a large deficit in muscle force.46,47 Crucially, it is shown that while motoneurons
within the muscle are dramatically affected by VML, this is not accompanied by death of
associated CNS neurons, suggesting that promoting the innate ability of peripheral nerves to
regenerate within the muscle may improve the functional outcome of VML. Further, Given that
skeletal muscle following denervation is host to a variety of cells including Schwann cells48, it
may be the case that Schwann cells from the minced muscle graft are better able to participate in
functional axonogenesis when combined with the DSM substrate which bridges normal muscle
with the wound. As with normal muscle, the DSM exhibits a longitudinally aligned character;
several studies suggest that scaffold alignment is a key factor in expediting axonogenesis49-52
with a recent finding that treatment of VML with a combination of aligned scaffolds and
rehabilitative exercise increases the formation of mature neuromuscular junctions.53 Further
study is required to better ascertain whether the aligned character of muscle matrix combined
with autologous minced muscle may mediate functionally relevant nerve regeneration following
VML.
Our observation of prolonged phagocytosis related transcription suggests a significant
presence of macrophages or other phagocytic cell types at the implant site. While the recruitment
of macrophages as part of the acute wound response and foreign body response to implants are
well described, direct participation of these cells in a variety of regenerative processes are
becoming better appreciated.54,55 Intriguingly, Stratton et al recently demonstrated that
macrophages regulate Schwann cell function during regeneration, with ablation of macrophages
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associated with the injury site resulting in marked reductions in conduction velocity and
remyelination mediated by the absence of macrophage-derived GAS6.56 Recent research
suggests that aligned scaffolds contribute to peripheral nerve regeneration by polarizing
macrophages toward a pro-regenerative phenotype, enhancing the proliferation and migration of
Schwann cells, again suggesting a potential role for the aligned character of minced muscle
coated DSM in mediating force recovery in VML.57
Our data suggest the involvement of several key neuritogenesis, axonogenesis, and axon
guidance transcripts in VML repair in the early period following injury; interrogation of these
and other factors influencing nerve regeneration within injured skeletal muscle is relatively
unexplored, and may yield fruitful targets exploitable by a combination of drug and biomaterialsbased therapies. Studies of global transcriptome expression have revealed that the cellular
community of skeletal muscle expresses a massive quantity of alternatively spliced transcripts,
the identities and quantities of which change substantially during the course of myogenesis.58
The levels of these isoforms are determined largely by the splicing event –not by changes in
transcription- resulting in these changes being unassessed in standard differential expression
analyses.59 Clearly, functional analysis of alternatively spliced isoforms expressed in skeletal
muscle during injury and intervention will develop a fuller understanding of muscle
pathobiology and repair. It is anticipated that investigations in this area will benefit greatly from
high sequencing depth and the application of cell sorting technologies for emerging single-cell
RNA sequencing (scRNA-seq), potentially allowing for the crucial distinction of expression
between the many cell types present in the muscle during injury and wound-healing.
Ultimately, VML injuries exhibit significant heterogeneity. Therefore, a range of clinical
strategies incorporating effective biomaterials, drugs, and physical rehabilitation will be required

143

to best address the complications of this challenging condition. As the expense of RNAsequencing technologies decreases and the ease of downstream data analysis increases, whole
transcriptome expression profiling will be an invaluable tool in guiding the development of
promising therapies for the treatment of VML.
D. Methods
Animals
26 Sprague Dawley rats (pre-surgical mass ~350 g) were used in this study.
Buprenorphine (0.1 mL at 0.3 mg/mL) was administered to all rats subcutaneously for
postoperative analgesia and access to Rimadyl was provided at up to 1 mg per day for seven days
post-injury. Food and water were provided ad libitum. All animal procedures were approved by
the Institutional Animal Care and Use Committee of the University of Arkansas.
Injury and repair
VML injuries were created in rats using an established VML model.60 Briefly, Lateral
incisions were made on the lower left legs of Sprague Dawley rats weighing ~350 g, separating
skin and fascia to expose the TA muscle. An 8 mm biopsy punch was used to remove muscle
tissue (~100 mg) from the middle third of the TA to a depth of 3 mm. Subsets of rats underwent
repair of VML injury with autologous minced muscle grafts (MM), SDS/DNase I/RNase A
decellularized skeletal muscle prepared from rat tibialis anterior (DSM), and a combination of
DSM and MM (DSM+MM). MM autografts were prepared during surgery by mincing the
biopsied tissue using microscissors. Fascia and skin were closed using interrupted stiches with 60 Vicryl sutures. Buprenorphine every administered subcutaneously every eight hours for postoperative analgesia.
Functional assessment
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Peak tetanic contractile force of injured and contralateral normal limbs was measured in
situ at three days and fourteen days post-injury as previously described.25 Briefly, peroneal
nerves of anesthetized rats were stimulated (150 Hz, 0.1 ms pulse width, 400 ms pulse train) by
an S88 pulse stimulator (Grass Technologies, West Warwick) to induce contraction of the tibialis
anterior muscle. Measurement of raw force output (N) was enabled by securing the foot of the
limb to a force transducer system (Aurora Scientific, Ontario) with surgical tape. Peak tetanic
force for each limb was calculated by the mean of three contractions and normalized to animal
mass (N/kg body weight).
RNA preparation and sequencing
TA muscles were harvested from euthanized rats at three days and fourteen days postinjury, snap frozen on liquid nitrogen, and stored at -80°C pending RNA isolation. Tissues were
thawed and homogenized for 15 s at room temperature. Total RNA was isolated using the
Purelink RNA Mini Kit (ThermoFisher). RNA concentration was determined by nanodrop
spectrophotometry, with RNA quality (28S/18s >2, RIN >7) confirmed using a Tapestation
(Agilent Technologies). cDNA libraries were sequenced on the BGISeq-500 platform to a mean
depth of 20,000,000 reads per library.
RNA-seq data analysis
RNA sequencing reads were mapped to the Rattus norvegicus genome (RGSC build 6.0)
from USCS using the 2-pass STAR protocol61. Reads were quantified using FeatureCounts62,
followed by analysis of differential expression and normalization in edgeR63. Differential
expression was called using a false discovery rate (FDR) cutoff of 0.05 and absolute minimum
fold change of 1.5. Visualization of group intersections for differential gene expression was
performed using UpsetR64. Enrichment analysis of gene sets was performed against the
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Biological Process Gene Ontology and KEGG databases in ShinyGO.65 Pathway level analysis
was also performed using Ingenuity Pathway Analysis (Qiagen)66.
Statistics
Statistical analyses for assessment of muscle force were performed using Prism 7
(Graphpad, La Jolla, California), using repeated measures ANOVA with post-hoc Dunnett’s test.
Assessment of significance for differential gene expression was performed using EdgeR with
TMM normalization of read counts and adjustment of p-values for multiple comparisons by the
Benjamini-Hochberg procedure. Significance was accepted at P ≤ 0.05 (*) P ≤ 0.01 (**), P ≤
0.001 (***), and P ≤ 0.0001 (****). Quantitative data are displayed as mean + standard
deviation.
Data availability
All RNA-sequencing files were deposited in the Gene Expression Omnibus
(https://www.ncbi.nlm.nih.gov/geo/) under accession number GSE125896. All other data
supporting the findings of this study are available from the authors upon reasonable request.
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G. Appendix
Figure Legend:
Figure 1: Creation of VML injuries and subsequent repair strategies.
Rat tibialis anterior muscles were subjected to VML following implant repair strategies including
minced muscle (MM), decellularized skeletal muscle (DSM), and a combination of the two
(DSM+MM).

Figure 2: Codelivery of decellularized skeletal muscle with minced muscle preserves muscle
contractile force.
(Top) Gross appearance of tibialis anterior muscles for groups at three and fourteen days post
injury (DPI). (a and b) Tibialis anterior mass (g/kg rat body weight) at three and fourteen DPI,
respectively. Electrophysiological measurement of mean peak contractile force of the tibialis
anterior for all groups at (c) three and (d) fourteen DPI, respectively, indicating deficits in
functional outcome among VML, MM, and DSM-treated muscles relative to the uninjured
contralateral limb at 14 DPI (p <0.0001, <0.0001, and 0.0003, respectively). DSM+MM
exhibited a significant deficit in force at 3 DPI but not 14 DPI. Error bars are presented as ±
standard deviation.
Figure 3: Global transcription within the VML cell community diverges profoundly based
on repair strategy.
(a) Heatmap of log2FC for all differentially expressed genes (DEGs) across all groups, with
hierarchical clustering of gene expression data visualized using one minus Pearson correlation
with average linkage. (b) Visualization of the top 15 DEG intersections across groups was
performed using UpsetR, with (c) significantly overrepresented gene sets for the top 3
intersections assessed by querying the Gene Ontology Biological Process database.

Figure 4: Myogenesis and angiogenesis transcription are insensitive to VML repair.
(a) Heatmap of Log2FC with (b) mean ± standard deviation plots of normalized expression
counts for transcript-level markers of myogenesis and (c) heatmap of Log2FC and (d) mean ±
standard deviation plots of normalized expression counts for transcript-level markers of
angiogenesis.
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Figure 5: Highly upregulated extracellular matrix constituent transcription persists in
DSM and DSM+MM repair.
(a) Heatmap of Log2FC and (b) mean ± standard deviation plots of normalized expression counts
for extracellular matrix transcripts.
Figure 6: Highly upregulated phagocytosis associated transcription persists in DSM and
DSM+MM repair.
(a) Heatmap of Log2FC and (b) mean ± standard deviation plots of normalized expression counts
for phagocytosis related transcripts.
Figure 7: Neuritogenesis and axonogenesis transcription are significantly increased in
DSM+MM repair
(a) Heatmap of Log2FC with (b) mean ± standard deviation plots of normalized
expression counts for transcript-level markers of neuritogenesis and (c) heatmap of Log2FC with
(d) mean ± standard deviation plots of normalized expression counts for transcript-level markers
of axonogenesis.
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Chapter 6
Conclusion
Despite significant advances in the past decade in the engineering of therapeutic
biomaterials at the lab scale, little change has occurred in the fundamental clinical practice of
treating VML. The ~22 human subjects evaluated across 4 VML clinical reports1-4 of ECMbased therapies exhibit substantial variation in degree and site of injury which makes rigorous
assessment of implant efficacy difficult. Additionally, the differing methods for assessing
functional outcome between clinical studies and the broad preclinical VML literature suggest a
need for future animal studies to add additional clinically relevant measures of functional
recovery such as measures of range of motion. While electrophysiological stimulation provides a
precise absolute measure of force recovery, this is generally replaced in humans subjects with the
application of dynamometers, and the lack of biomechanical data in animals beyond raw force
makes comparison to clinical reports difficult; application of a standardized noninvasive
electrophysiological stimulation approach5 between preclinical and clinical studies of VML may
improve confidence in the clinical relevance of preclinical force data. Overall, a more controlled
approach to clinical evaluation of VML therapies is necessary for translation of promising labscale therapies to the clinic. In particular, an opt-in HIPAA-compliant registry of clinical data
from VML subjects -similar to those used for subject recruitment in cancer and diabetes
research6- would enable improved communication between researchers and clinicians for
mobilizing appropriate subjects for controlled trials.
A significant challenge in treating VML is that musculoskeletal clinicians are most likely
to encounter patients long after their initial injury, when the site of the wound has already
remodeled into a fibrotic mass which precludes regeneration of normal tissue. While the
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magnitude of fibrosis in massive musculoskeletal trauma can be greater than that in the
degenerative fibrosis of other tissues, recent findings suggesting the ability of specific
compounds to revert fibrosis in the heart7, liver8, and other tissues9 may be of use to the filed.
Most VML preclinical studies have understandably focused on the idealized scenario of
immediate repair of injury; given that this ideal is not reflected in the clinic, assessing the ability
of biomaterials to promote functional regeneration long after the initial injury would provide
clinically relevant insight. A transcriptomic study of VML in male rats was presented in chapter
5 suggesting that muscle force may be preserved in DSM+MM treatment of muscle, that
promotion of neuroregenerative signaling may play a role in mediating this preservation, and that
this preservation can be brought about in the two weeks following injury. Therefore, despite the
(typically) months of time between the initial VML injury and onset of recuperative therapies,
beginning therapeutic interventions immediately after injury may be critical to outcome. As the
biological understanding of the skeletal muscle cell community in VML improves, it is evident
that key biochemical information informing the design of therapeutic biomaterials will be more
readily available. Specifically, elucidating key molecular mechanisms mediating skeletal muscle
regeneration, inflammation, fibrosis, and innervation will provide tangible molecular targets
which materials can be engineered to affect, by inclusion of exogenous molecules that act on
specific pathways or by the codelivery of purposely-conditioned cells.
VML researchers have evaluated the effects of biological scaffolds and some myogenic
precursor cell delivery on functional outcome, but this has generally occurred with little
deliberate engineering of materials and cells for the microenvironment of skeletal muscle;
certainly the cellular heterogeneity of any injured tissue complicates the usefulness of omics data
in guiding the design of therapies, but recent advances in cell sorting for these technologies are
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already providing a wealth of remarkably informative data for the regeneration of various tissues
that is currently missing in VML.10-14 Of the three investigations applying RNA-sequencing to
VML injury and repair15,16 -including that of this author described in chapter 5- none isolate the
global transcriptomic response of specific cell types in VML. Additionally, missing from the
VML research community is the application of other next-generation technologies such as
quantitative mass spectrometry proteomics.17 Integration of data from transcriptomic and
proteomic methods is currently providing to other areas of biology18-21 a more comprehensive
screening of relevant cell behavior than classic methods (qPCR, western blot, etc.), and it is the
opinion of this author that the collective understanding of VML pathobiology and repair will
benefit greatly from their application. Further, the continually decreasing financial cost of these
techniques is anticipated to lead to their application in personalized medicine22, and the strategic
decision to apply omics technologies to VML research now will provide datasets that would
doubtlessly inform the development of future therapies.
Polymorphisms of individuals impairing peripheral nerve regeneration, myogenesis, and
the inflammatory-to-constructive myeloid cell transition are key examples of personalized
treatment targets assessable by next generation techniques. While sex differences in the outcome
of VML-specific therapies have not been targeted for study thus far, the 2016 implementation of
the Sex as a Biological Variable (SABV) policy by the NIH is expected to ameliorate this
shortcoming. Interestingly, limited study demonstrates that female muscle-derived stem cells
exhibit a capacity for regeneration greater than their male counterparts23, with the mechanism
responsible remaining unclear. Thus, not only may outcome vary between the sexes, but the
expectation that female donor cells outperform those of males also necessitates that future
studies report and consider the sex of delivered cells in their analyses.
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In addition to adopting more high throughput methods for analyzing transcriptomic and
proteomic changes relevant to VML and potential interventions, a redoubled exploration of
musculoskeletal molecular biology may be clinically useful; in particular, study of epigenetic
changes such as DNA methylation at cytosine-guanine (CpG) dinucleotides, histone
modification, and noncoding RNA expression may play roles in muscle injury and regeneration.
Epigenetic modifications are both reversible and can cause pathologically relevant changes in
gene expression, with several inhibitors of histone deacetylation and DNA methylation having
been FDA-approved and clinically applied.24 Notably, evidence suggests that DNA methylation
is in activating the expression of several genes during the commitment of cells to a myogenic
lineage.25 For example, the activation of the myogenic gene program following satellite cell
activation is now known to be mediated by decreases in NAD+ and a consequent decrease in the
deacetylase SIRT1, allowing for increased acetylation of lysine 16 of histone 426, a particularly
important site whose acetylation leads to conversion of heterochromatin to euchromatin, making
sites throughout the genome more accessible for transcription.27 DNA methylation itself is
known to increase substantially during aging with such predictability that one group developed a
DNA methylation model which predicts age from DNA methylation profile with a correlation of
96% and error of approximately 3 years.28 Sarcopenia29 and reduced satellite cell content30 are
observed in the elderly, with SPRY1 being one site of age-associated DNA methylation resulting
in reduction of the available pool of quiescent satellite cells.31 Interestingly, acute exercise has
been shown to reduce methylation of genomic sites associated with skeletal muscle metabolism,
suggesting a role for methylation in the effects of physical therapy in the elderly and a specific
mechanism by which increased activity may minimize the deleterious effects of aging on skeletal
muscle.32,33 Whole genome bisulfite sequencing is the current gold-standard tool for detection of
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DNA methylation34 and its application in combination with transcriptomic and proteomic
techniques will provide an additional layer of biological insight for VML treatment.
Noncoding RNAs (ncRNAs) are RNA molecules which have independent functions and
do not generally undergo translation into peptides, with many functioning to regulate gene
expression across the transcriptome.35 A number of ncRNAs have been shown to govern satellite
cell proliferation and differentiation.36-38 Circular RNAs (circRNAs) are a relatively unexplored
class of RNA molecules which are relatively stable compared to their linear counterparts, with
some demonstrated potential to bind microRNA molecules.39 NcRNAs -including circRNAs- are
in some cases enriched in exosomes40,41, including those of muscle-resident cells, with the
potential to directly affect the muscle fibrosis and regeneration.42,43 Recent direct evidence of
cell-to-cell contacts and exosome exchange between macrophages and satellite cells from
activation through myoblast fusion suggests a direct intracellular crosstalk which could be
mediated in part by the exchange of noncoding RNAs; elucidating the identities and functions of
relevant noncoding RNAs in skeletal muscle and their responses to injury and biomaterial
therapies should therefore be yet another goal in bettering the collective understanding of VML
pathobiology.
Remarkable insights have recently been made in the understanding of vertebrate limb
regeneration observed in Urodela amphibians which are relevant to muscle regeneration. While
humans have homologs for many of the same key limb regeneration associated genes as
Urodela, in practice these are not typically expressed following injury. Limb-regenerating
vertebrates mobilize the dedifferentiation of injury-adjacent cells to form a blastema, from which
these cells can redifferentiate to reform the complete range of tissues in a limb.44 Interestingly,
the dedifferentiated cells do not appear to be fully pluripotent; rather, they retain a memory of
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their tissue origin and remain committed to a tissue-specific lineage. For example,
dedifferentiated skeletal muscle cells contribute to reformation of skeletal muscle in a limb but
do not contribute to cartilage formation.45 Recapitulating this process in humans is considered to
be eventually feasible, but recent estimates of treatment time indicate that the time course for
complete regeneration of a whole limb from a functioning blastema would likely range from 2-5
years, with complex pharmacological cues to guide morphogenesis throughout treatment.46
Forming a functional blastema in humans is an awesome interdisciplinary challenge which will
require extensive series of studies mapping the process as it exists in current models and
engineering human cells to mimic it. A complete genome sequence for the critical regenerative
model Ambystoma mexicanum was only recently published in 201847 with a chromosome-scale
assembly of the massive 32 Gb genome released in early 2019.48 A complete definition of the
molecular mechanisms mediating blastema formation in both amphibian models and mammalian
digit tip regeneration will be a necessary step toward limb regeneration.49 Despite the enormous
technical challenges involved, limb regeneration in amphibians is the only extensively
characterized example of complete vertebrate muscle regeneration following VML, and so
engineering this process in human cells -which retain much of the necessary machinery
involved- might be the most fruitful approach for achieving complete functional regeneration
over the long term.
Autologous muscle transfer is occasionally performed as a treatment for muscle loss, but
clearly results in morbidity at the donor site (typically the latissimus dorsi first used for head and
neck reconstruction in 197850 or the gracilis51-54) and can require a prohibitively large volume of
tissue in the case of VML.55 Thus, there is interest in the in vitro production of tissue-like
constructs that could be transplanted. Regarding the in vitro production of ECM scaffolds which
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provides finer control over implant composition and architecture, scale-up of methods for the
bulk production of ECM will be needed to generate a clinically useful amount of tissue. A
number of bioreactor schemes are available that could be applied for this purpose, including
existing hollow fiber membrane bioreactors with the potential to leverage the productivity of cell
densities as high as 1010 cells per membrane cartridge.56 The rapid proliferation of mammalian
cells in dynamic bioreactors additionally provides the opportunity for expansion of a patients’
own precursor cells and, thereby, production of an autologous ECM minimizing foreign epitopes
and their inflammatory consequences. A new approach for producing ECM in vitro was
described in chapters 2 and 3 whereby asymmetric hollow fiber membranes are used as a
sacrificial cell culture substrate for mammalian cells, with ECM isolated through the dissolution
of the membrane by an appropriate solvent as continuous threads of whole matrix. While the
effectiveness of implants derived from these threads in the treatment of VML is the subject of an
ongoing preclinical study, several avenues exist to improve upon this first generation of
sacrificial culture-derived ECM. The current platform is based on the static culture of fibroblasts
on hollow fibers, and therefore does not leverage the aforementioned benefits of dynamic
bioreactor culture with commercial membrane cartridges; evaluating sacrificial hollow fiber cell
culture at a pilot scale will better reveal the feasibility of this approach for satisfying a
commercial demand for ECM. A recognized concern in the approach is the use of irritating
solvents such as N-methyl-2-pyrrolidone (NMP) in the isolation of ECM from the sacrificial
membranes. While overall proteinaceous composition and retention of ECM constituents within
the resulting scaffolds is demonstrated in chapter 2, the potential effects of such solvents on
scaffold composition have not been extensively evaluated, and so the process may benefit from
modifications allowing for omission of solvent use. A promising approach may be to capitalize
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upon the development of thermally responsive polymers such as PNIPAAM which can be
dissociated from cells and ECM by a modest change in temperature. Conveniently, processes for
preparing PNIPAAM-grafted hollow fibers are described in the literature57-59 and have even been
successfully exploited for isolation of adhered mammalian cells through the thermal dissociation
mechanism.59 Hu et al also developed a spinning process for producing wholly NIPAAM hollow
fibers which could allow for streamlining the fabrication and cell culture processes into a single
simultaneous step.60
In summary, VML is a challenging pathology which will require the coordinated
interdisciplinary efforts of biologists, tissue engineers, materials scientists, and clinicians to
address adequately. Clearly, much remains to be learned in terms of the molecular processes
governing the homeostasis of normal skeletal muscle, let alone the processes relevant to recovery
of muscle from severe trauma. However, new technologies now allow for their characterization
at the genomic, epigenomic, transcriptomic, and proteomic scales which are expected to reveal
clinically useful targets. Some biomaterial and cell delivery therapies for VML have been
developed at the lab scale -including the DSM+MM approach- and have shown promising results
at the preclinical stage. As the DSM component of this specific approach would likely require
FDA regulatory approval, it may be prudent to begin assessing the approach across multiple
animal models in anticipation of the regulatory process. Alternatively, clinical application of
MM itself would not require regulatory approval. Regardless of the specific promising
approaches that are translated, the differing methods for assessing functional outcomes
(dynamometers, electrostimulation, etc.) in the preclinical and clinical settings should be unified
to enhance the predictive value of VML animal studies on clinical outcome. In the longer term,
developments in mammalian bioreactor systems and ECM isolation may enable the commercial
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production of ECM with more control over implant architecture and composition than is allowed
with the simple decellularization of cadaveric tissues, with the possibility of proliferating a
patients’ own cells, enabling the engineering of personalized ECM implants. Further yet, the
recent insights into limb regeneration in amphibian models and the conservation of relevant
genes across vertebrates hold the distant promise of leveraging the latent regenerative potential
of dedifferentiated cells, gene therapies, and pharmacological treatments for complete
regeneration of the tissue community of skeletal muscle from severe trauma.
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Appendix
Effect of Autologous Muscle Graft Alignment on VML Outcome

Figure 1
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Figure 2
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Figure Legend
Figure 1: Graft Alignment Correlates With Degree of Intramuscular Collagen
Deposition
Collagen I (green) and MHC (red) composite immunofluorescence imaging for (A) uninjured,
(B) 0°, (C) 45°, and (D) 90° alignment groups at 12 weeks post injury, with (E) image analysis
for noncontractile tissue area as a percent of total thresholded area. Scale-bar = 100 µm.
Figure 2: Transcriptome Profiling of Graft Alignment
(A) Heatmap of log2FC for all differentially expressed genes (104 unique DEGs) across all 0°
and 90° groups relative to uninjured contralateral limbs at 2 weeks post-injury. (B)
Visualization of the top DEG intersections across all groups with (C) the top canonical
pathways for each group identified by Ingenuity Pathway Analysis.

Figure 3: Autologous Graft Excision and Reinsertion
(A) Graphical schematic of graft excision and reinsertion, with gross imaging of (B) biopsy,
(C) defect creation, (D) graft alignment, and (E) graft reinsertion.
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